GBT (GTCH) 10-K 31 Mar 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 24, 2021	Jun. 30, 2020
Document And Entity Information
Entity Registrant Name	GBT Technologies Inc.
Entity Central Index Key	0001471781
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity File Number	000-54530
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV
Entity Public Float			$ 1,157,141
Entity Common Stock, Shares Outstanding		493,110,305
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
ICFR Auditor Attestation Flag	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)		Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash		$ 113,034	$ 59,634
Cash held in trust		402,532
Marketable equity security		649,000	1,000,000
Assets of discontinued operations			206,809
Total current assets		1,164,566	1,266,443
Convertible note receivable			4,000,000
Total assets		1,164,566	5,266,443
Current liabilities:
Accounts payable and accrued expenses (including related parties of $410,833 and $334,000)		3,353,658	1,814,609
Accrued settlement		4,090,057	4,090,057
Convertible notes payable, net of discount of $362,004 and $0		13,426,706
Note payable, net of discount of $0 and $47,671		2,741,737	5,923,590
Derivative liability		5,262,448
Liabilities of discontinued operations			1,151,073
Total current liabilities		28,874,606	12,979,329
Convertible notes payable			11,000,000
Note payable		148,263
Total liabilities		29,022,869	23,979,329
Contingencies
Stockholders' Equity (Deficit):
Common stock, $0.00001 par value; 100,000,000,000 shares authorized; 256,674,458 and 16,536,351 shares issued and outstanding at December 31, 2020 and 2019		6,711	4,310
Treasury stock, at cost; 1,040 shares at December 31, 2020 and 2019		(643,059)	(643,059)
Stock loan receivable		(7,610,147)	(7,610,147)
Additional Paid In Capital		251,039,531	242,192,461
Accumulated deficit		(270,651,339)	(252,656,451)
Total stockholders' deficit		(27,858,303)	(18,712,886)
Total liabilities and stockholders' deficit		1,164,566	5,266,443
Series B Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred stock value	[1]
Series C Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred stock value	[2]
Series D Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred stock value	[3]
Series G Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred stock value	[4]
Series H Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred stock value	[5]
[1]	Series B Preferred stock, $0.00001 par value; 20,000,000 shares authorized; 45,000 and 45,000 shares issued and outstanding at December 31, 2019 and 2018
[2]	Series C Preferred stock, $0.00001 par value; 10,000 shares authorized; 700 and 700 shares issued and outstanding at December 31, 2019 and 2018
[3]	Series D Preferred stock, $0.00001 par value; 100,000 shares authorized; 0 and 0 shares issued and outstanding at December 31, 2019 and 2018
[4]	Series G Preferred stock, $0.00001 par value; 2,000,000 shares authorized; 0 and 0 shares issued and outstanding at December 31, 2019 and 2018
[5]	Series H Preferred stock, $0.00001 par value ($500.00 stated value); 40,000 shares authorized; 20,000 shares issued and outstanding at December 31, 2019

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accounts payable and accrued expenses related party	$ 410,833	$ 334,000
Note payable discount	0	47,671
Discount	$ 362,004	$ 0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, authorized	100,000,000,000	100,000,000,000
Common stock, issued	256,674,458	16,536,351
Common stock, outstanding	256,674,458	16,536,351
Treasury stock	1,040	1,040
Series B Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized	20,000,000	20,000,000
Preferred stock, issued	45,000	45,000
Preferred stock, outstanding	45,000	45,000
Series C Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized	10,000	10,000
Preferred stock, issued	700	700
Preferred stock, outstanding	700	700
Series D Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized	100,000	100,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Series G Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized	2,000,000	2,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Series H Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized	40,000	40,000
Preferred stock, issued	20,000	20,000
Preferred stock, outstanding	20,000	20,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Sales:
Sales - related party	$ 180,000	$ 180,000
Operating expenses:
General and administrative expenses	2,041,996	126,986,423
Marketing expenses	310,840	869,143
Acquisition costs		150,000
Impairment of assets	5,600,000	48,631,534
Total operating expenses	7,952,836	176,637,100
Loss from operations	(7,772,836)	(176,457,100)
Other income (expense):
Amortization of debt discount	(4,197,550)	(6,821,453)
Change in fair value of derivative liability	(1,533,610)	7,290,867
Interest expense and financing costs	(2,949,849)	(6,215,457)
Unrealized loss on marketable equity security	(671,000)	(6,525,317)
Realized gain (loss) on disposal of marketable equity security	(424,830)	(90,683)
Loss on exchange of assets	1,430,000
Equity income in investment		631,534
Gain on settlement of debt		1,375,556
Total other income (expense)	(11,206,839)	(10,354,953)
Loss before income taxes	(18,979,675)	(186,812,053)
Income tax expense
Loss from continuing operations	(18,979,675)	(186,812,053)
Discontinued operations:
Loss from operations of discontinued operations	(16,924)	(1,074,869)
Gain on disposition of discontinued operations	1,001,711	1,381,803
Loss from discontinued operations, net	984,787	306,934
Net loss	$ (17,994,888)	$ (186,505,119)
Weighted average common shares outstanding:
Basic and diluted	159,992,976	4,786,694
Net loss per share (basic and diluted):
Continuing operations	$ (0.12)	$ (39.03)
Discontinued operations	0.01	0.06
Net loss per share basic and diluted	$ (0.11)	$ (38.96)

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Series B Convertible Preferred Stock	Series C Convertible Preferred Stock	Series D Convertible Preferred Stock	Series G Convertible Preferred Stock	Series H Convertible Preferred Stock	Common Stock [Member]	Treasury Stock	Loan Receivable	Paid-In Capital	Accumulated Deficit	Total
Balances at beginning at Dec. 31, 2018						$ 3,822	$ (643,059)		$ 81,306,958	$ (66,151,332)	$ 14,516,389
Balances at beginning (in shares) at Dec. 31, 2018	45,000	700				1,822,243	1,040
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for joint venture						$ 100			17,899,900		17,900,000
Common stock issued for joint venture (in shares)						10,000,000
Common stock issued for services						$ 10			235,890		235,900
Common stock issued for services (in shares)						9,500
Common stock issued for conversion of convertible debt and accrued interest						$ 75			1,420,059		1,420,134
Common stock issued for conversion of convertible debt and accrued interest (in shares)						74,762
Common stock issued for stock loan						$ 200		(7,610,147)	7,609,947
Common stock issued for stock loan (in shares)						200,267
Common stock issued for penalty						$ 59			975,006		975,065
Common stock issued for penalty (in shares)						59,820
Common stock issued for cashless exercise of warrants						$ 46			(46)
Common stock issued for cashless exercise of warrants (in shares)						4,566,214
Cancellation of shares for exchange of Mobiquity shares						$ (2)			(797,998)		(798,000)
Cancellation of shares for exchange of Mobiquity shares (in shares)						(200,000)
Series H preferred stock issued for acquisition									8,400,000		8,400,000
Series H preferred stock issued for acquisition (in shares)					20,000
Stock options issued for services									766,804		766,804
Fair value of beneficial conversion feature of converted/debt repaid									2,264,578		2,264,578
Relative fair value of warrants issued with convertible debt									1,634,760		1,634,760
Fair value of warrants issued									$ 120,476,603		$ 120,476,603
Rounding of shares due to stock split
Rounding of shares due to stock split (in shares)						3,545
Net loss										(186,505,119)	$ (186,505,119)
Balances at ending at Dec. 31, 2019						$ 4,310	$ (643,059)	(7,610,147)	242,192,461	(252,656,451)	(18,712,886)
Balances at ending (in shares) at Dec. 31, 2019	45,000	700			20,000	16,536,351	1,040
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for conversion of convertible debt						$ 1,401			1,309,678		1,311,079
Common stock issued for conversion of convertible debt (in shares)						140,138,107
Common stock issued for joint venture						$ 1,000			5,499,000		5,500,000
Common stock issued for joint venture (in shares)						100,000,000
Fair value of beneficial conversion feature of converted/debt repaid									2,038,392		2,038,392
Net loss										(17,994,888)	(17,994,888)
Balances at ending at Dec. 31, 2020						$ 6,711	$ (643,059)	$ (7,610,147)	$ 251,039,531	$ (270,651,339)	$ (27,858,303)
Balances at ending (in shares) at Dec. 31, 2020	45,000	700			20,000	256,674,458	1,040

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows From Operating Activities:
Net loss	$ (17,994,888)	$ (186,505,119)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment	46,363	107,095
Amortization of intangible assets		358,266
Amortization of debt discount	4,197,550	6,821,453
Change in fair value of derivative liability	1,533,610	(7,290,867)
Financing cost	1,343,847	4,356,699
Shares issued for services		235,900
Shares issued for penalty		975,065
Convertible note issued for penalty	242,712
Warrant issued for services		766,804
Fair value of warrants issued in accordance with anit-dilution		120,476,603
Impairment of assets	5,600,000	48,631,534
Unrealized (gain) loss on market equity security	671,000	6,525,317
Realized gain on disposal of market equity security	424,830	90,683
Loss on exchange of assets	1,430,000
Equity income in investment		(631,534)
Gain on disposition of discontinued operations	(1,001,711)	(1,381,803)
Convertible note receivable exchanged for services	200,000	1,000,000
Gain on settlement of debt		(1,375,556)
Changes in operating assets and liabilities:
Accounts receivable	1,674	(616,084)
Cash held in trust	172,638
Prepaid expenses		16,000
Accounts payable and accrued expenses	2,137,949	1,720,799
Unearned revenue		(257,848)
Accrued settlement		55,613
Due to Guardian, LLC		(702,483)
Net cash used in operating activities	(994,426)	(6,623,463)
Cash Flows From Investing Activities:
Purchase of property and equipment	(4,200)	(17,471)
Cash paid for investment		(1,200,000)
Cash of discontinued operations	(227,571)	(270,947)
Cash from the sale of marketable equity security		336,000
Net cash used in investing activities	(231,771)	(1,152,418)
Cash Flows From Financing Activities:
Issuance of convertible notes	820,958	3,000,000
Issuance of notes payable	458,639	3,071,261
Payments on notes payable		(99,256)
Net cash provided by financing activities	1,279,597	5,972,005
Net increase (decrease) in cash	53,400	(1,803,876)
Cash, beginning of period	59,634	1,863,510
Cash, end of period	113,034	59,634
Cash paid for interest		744
Cash paid for income taxes
Supplemental non-cash investing and financing activities
Debt discount	4,511,883	3,636,000
Transfer of derivative liability to equity	1,899,557	2,264,578
Convertible notes issued for notes payable and accrued interest	3,738,171
Common stock issued for convertible notes and accrued interest	$ 1,311,079

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	Note 1 – Organization and Basis of Presentation Organization and Line of Business GBT Technologies Inc. (formerly Gopher Protocol Inc.) (the “Company”, “GBT”, or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. The Company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. Effective August 5, 2019, the Company changed its name from Gopher Protocol Inc. to GBT Technologies Inc. The Company derived revenues from (i) the provision of IT services; and (ii) from the licensing of its technology. Basis of Presentation The accompanying consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Stock Split On August 5, 2019, the Company effectuated a 1 for 100 reverse stock split. The share and per share information has been retroactively restated to reflect this reverse stock split. Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has an accumulated deficit of $270,651,339 and has a working capital deficit of $27,710,040 as of December 31, 2020, which raises substantial doubt about its ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include valuation of derivatives and valuation allowance on deferred tax assets. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned AltCorp Trading LLC, a Costa Rica company (“AltCorp”) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich”). All significant intercompany transactions and balances have been eliminated. Cash Equivalents For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2020, and 2019, the Company did not have any cash equivalents. Cash Held in Trust Cash held in trust consists of proceeds from the sale of investments. The proceeds less the payment of certain expenses are being held in AltCorp’s (the Company’s wholly owned subsidiary) attorney trust account. (See Note 4) Long-Lived Assets The Company applies the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 360, Property, Plant, and Equipment Marketable Equity Securities The Company accounts for marketable equity securities in accordance with ASC Topic 321, Investments – equity securities. Note Receivable Note receivable consists of a promissory note received in connection with the sale of Ugopherservices (see Notes 3, 4 and 17). The note is due on December 31, 2021 and accrues interest at 6% per annum. At December 31, 2020, the Company determined that this note receivable was not collectible and took an impairment charge of $100,000. Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2020, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion. During the year ended December 31, 2019, the convertible notes with embedded conversion features were settled; therefore, there was no derivative liability at December 31, 2019. Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities. FASB ASC Topic 820, Fair Value Measurements and Disclosures Financial Instruments ● Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. ● Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement. The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity Derivatives and Hedging For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their fair values were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. At December 31, 2020 and 2019, the Company identified the following liabilities that are required to be presented on the balance sheet at fair value: Fair Value Fair Value Measurements at As of December 31, 2020 Description December 31, 2020 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Marketable equity security - Surge Holdings, Inc. $ 649,000 $ - $ 649,000 $ - Conversion feature on convertible notes $ 5,262,448 $ - $ 5,262,448 $ - Fair Value Fair Value Measurements at As of December 31, 2019 Description December 31, 2019 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Marketable equity security - Surge Holdings, Inc. $ 1,000,000 $ - $ 1,000,000 $ - Treasury Stock Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital. Stock Loan Receivable On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has pledged 200,267 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for a term of three years in consideration of an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company has recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principal to return the pledged 200,267 restricted shares to the Company for cancellation. The 200,267 restricted shares have not yet been returned to the Company as of December 31, 2020. Revenue Recognition Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Topic 606 Topic 606. Topic 605, Revenue Recognition Revenue is recognized under Topic 606 ● executed contracts with the Company’s customers that it believes are legally enforceable; ● identification of performance obligations in the respective contract; ● determination of the transaction price for each performance obligation in the respective contract; ● allocation the transaction price to each performance obligation; and ● recognition of revenue only when the Company satisfies each performance obligation. These five elements, as applied to each of the Company’s revenue category, is summarized below: ● IT services - revenue is recorded on a monthly basis as services are provided; and ● License fees and Royalties – revenue is recognized based on the terms of the agreement with its customer. Unearned revenue Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. In 2018, the Company ran pre-sales efforts for its pet tracker product and received prepayments for its product. In addition, during 2018, the Company received $200,000 in connection with an intellectual property license and royalty agreement. At December 31, 2019, the Company determined that the unearned revenue would not likely result in the recognition of revenue; therefore, $249,094 of unearned revenue was reclassified to accrued expenses at December 31, 2020 and 2019. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented. Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share December 31, December 31, 2020 2019 Series B preferred stock 30 30 Series C preferred stock 8 8 Series H preferred stock 1,000,000 1,000,000 Warrants 19,643,500 19,654,167 Convertible notes 481,351,062 1,100,000 Total 501,994,600 21,754,205 Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of December 31, 2020, through the date which the consolidated financial statements are issued. Based upon the review, other than described in Note 17 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements. Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes Income Taxes Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Discontinued Operations; Note R

Discontinued Operations; Note Receivable	12 Months Ended
	Dec. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations; Note Receivable	Note 3 – Discontinued Operations; Note Receivable On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD . On September 30, 2019, the Company entered into an Asset Purchase Agreement with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG all the assets and certain specified liabilities of its ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses in consideration of $5,000,000 to be paid through the issuance of 3,333,333 shares of SURG’s common stock and a convertible promissory note in favor of the Company in the principal amount of $4,000,000. The 3,333,333 shares of SURG’s common stock have been pledged to a third party for providing working capital needs of the Company (See Note 8). UGO, ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses have been presented as discontinued operations on the accompanying financial statements. The operating results for UGO, ECS Prepaid, Electronic Check Services and the Central State Legal Services have been presented in the accompanying consolidated statements of operations for the years ended December 31, 2020 and 2019 as discontinued operations and are summarized below: Years Ended December 31, 2020 2019 Revenue $ 8,291,842 $ 42,998,336 Cost of revenue 7,900,122 41,596,118 Gross Profit 391,720 1,402,218 Operating expenses 408,644 2,477,084 Loss from operations (16,924 ) (1,074,866 ) Other income (expenses) - (3 ) Net loss $ (16,924 ) $ (1,074,869 ) The assets and liabilities of the discontinued operations at December 31, 2020 and 2019 are summarized below: December 31, December 31, 2020 2019 Current assets $ - $ 89,123 Property and equipment - 117,686 Total assets $ - $ 206,809 Current liabilities $ - $ 1,151,073 Total liabilities $ - $ 1,151,073

Investment in Mobiquity Technol

Investment in Mobiquity Technologies, Inc. and Surge Holdings, Inc.; Convertible Note Receivable	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Investment in Mobiquity Technologies, Inc. and Surge Holdings, Inc.; Convertible Note Receivable	Note 4 – Investment in Surge Holdings, Inc. and Mobiquity Technologies, Inc.; Convertible Note Receivable Surge Holdings, Inc. On September 30, 2019, the Company entered into an Asset Purchase Agreement with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG, all the assets and certain specified liabilities, of its ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses in consideration of $5,000,000 to be paid through the issuance of 3,333,333 shares of SURG’s common stock (See Note 8 for pledge to third party) and a convertible promissory note in favor of the Company in the principal amount of $4,000,000 (the “SURG Note”), convertible into SURG’s shares of common stock following the six-month anniversary of the issuance date. The conversion price of the SURG Note is the volume weighted-average price of SURG’s common stock over the 20 trading days prior to the conversion; provided, however, the conversion price shall never be lower than $0.10 or higher than $0.70. The Company has agreed to restrict its ability to convert the SURG Note and receive shares of common stock such that the number of shares of common stock held by it in the aggregate and its affiliates after such conversion does not exceed 4.99% of the then issued and outstanding shares of common stock. The SURG Note is payable by SURG to the Company on the 18-month anniversary of the issuance date and does not bear interest. On or about June 23, 2020, the Company and AltCorp entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) regarding the $4,000,000 SURG Note for which the SURG Note has been converted in full into 5,500,000 restricted stock of SURG (“Issued Shares”) along with an additional 22,000,000 SURG shares reserved for the benefit of the Company’s subsidiary as a true up of shares to secure the value of the Issued Shares as $2,750,000. Additional shares will be issued if the original 5,500,000 are worth less than $2,750,000 on June 23, 2021. The Company agreed that the Issued Shares will be restricted for a year. As a result of the exchange of $2,750,000 of the SURG Note for 5,500,000 shares of SURG common stock, the Company recognized a loss of $1,430,000. See additional settlement entered into with SURG on January 1, 2021 in Note 17. Glen converted in full its $1,000,000 convertible note that was issued by the Company on July 8, 2019, plus $50,000 of accrued interest into $1,050,000 of a SURG Note via an assignment of a portion ($1,050,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. In addition, the Company entered into a consulting agreement with Glen for which the Company shall pay to Glen $200,000 via an assignment of a portion ($200,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. (See Note 8). On or about June 23, 2020, Stanley Hills LLC (“Stanley”) which holds a pledge of 3,333,333 shares of SURG common stock (See Note 8) via its manager/member (“Stanley’s Member”), acting as an agent for the Company, entered into an agreement with SURG, its transfer agent and an escrow officer for which it was agreed that 3,333,333 SURG shares will be cancelled for consideration of up to $700,000. Between sales to SURG and to a third party, the amount of $575,170 was received into a lawyer’s trust account for the benefit of AltCorp, and 3,333,333 of SURG shares have been sent for cancelation. The lawyer’s trust account balance is $402,532 as of December 31, 2020. On August 12, 2020, the Company and its subsidiary, AltCorp, entered into a new pledge agreement with Stanley, where 5,500,000 SURG shares been pledged to Stanley to secure the debt payable by the Company to Stanley as well as mitigate the damages allegedly created by SURG. On November 4, 2020, Altcorp and Stanley filed an Ex Parte Motion In the District Court, Clark County, Nevada (Case No: A-20-823039-B, in Dep No: 43) to appoint receiver and issue a temporary restraining Order against Surge and its transfer agent for alleged defaults on prior exchange agreement. As court entered an order minute granting in part AltCorp motion, the parties entered on December 4, 2020 an interim agreement which set the material terms of the settlement. A final settlement was achieved per the interim agreement terms on January 1, 2021. As of December 31, 2020, the Company’s investment in SURG consisted of 5,500,000 shares of SURG common stock which was valued at $649,000. (See Note 17 for Subsequent Events) Mobiquity Technologies, Inc (Divested in 2019). On September 4, 2018, the Company and Mobiquity Technologies, Inc., a New York corporation (“Mobiquity”) entered an agreement pursuant to which the parties exchanged equity interest in each of the companies. In accordance with the agreement, the Company received 1,000 shares of Mobiquity’s restricted Series AAAA Preferred Stock (the “Mobiquity Preferred Stock”) in consideration of Company’s concurrent sale and issuance to Mobiquity of 10,000,000 shares of Company’s common stock. The shares of Mobiquity Preferred Stock are convertible into an aggregate of up to 100,000,000 shares of Mobiquity common stock (the “Mobiquity Common Stock”) and 150,000,000 common stock purchase warrants (the “Mobiquity Warrants”). The Mobiquity Warrants shall have a term of 5 years from the date of grant and shall be exercisable at a price of $0.12 per share and the shares of Mobiquity Preferred Stock shall not be convertible into shares of Mobiquity Common Stock and the Mobiquity Warrants shall not be contemporaneously granted until after Mobiquity’s Board of Directors and stockholders shall have increased the authorized number of shares of Mobiquity’s common stock to a number sufficient to accommodate a reserve in the Company’s favor of 250,000,000 shares of Mobiquity’s common stock. The Mobiquity Preferred Stock shall have immediate voting rights equal to the number of shares of Mobiquity Common Stock into which they may be converted, not including the shares of Mobiquity’s common stock underlying the Mobiquity Warrants. On November 19, 2018, the Company and Mobiquity entered into an Amendment and Exercise Letter waiving the requirement that Mobiquity’s Board of Directors and stockholders increase the authorized number of shares of Mobiquity’s common stock to a number sufficient to accommodate a reserve in the Company’s favor of 250,000,000 shares of Mobiquity’s common stock prior to the conversion of the Mobiquity Preferred Stock or exercise of the Mobiquity Warrants. In addition, the Company converted 200 shares of Mobiquity Preferred Stock resulting in the issuance to the Company by Mobiquity of 20,000,000 shares of Mobiquity Common Stock and 30,000,000 Mobiquity Warrants. The Company exercised the 30,000,000 Mobiquity Warrants at an exercise price of $0.12 per share of common stock, payable through of the issuance to Mobiquity of 10,000,000 shares of common stock of the Company. In addition, the Company issued 20,000 shares of common stock to Glen Eagles Acquisition LP (“Glen”) in consideration of its consulting services associated with the negotiation of the number of shares of common stock to be delivered to Mobiquity upon exercise of the Mobiquity Warrants. As a result of the transaction on September 4, 2018, the Company had an approximate 21% interest in Mobiquity and began to account for its investment in Mobiquity using the equity method of accounting. During the fourth quarter of 2018, Mobiquity issued additional shares of common stock resulting in the Company’s ownership in Mobiquity dropping to approximately 18% at December 31, 2018. The Company determined that during the fourth quarter of 2018 that it did not exercise significant influence over Mobiquity due to its decreased ownership percentage and the Company’s intent to begin selling shares of Mobiquity common stock that will further decrease its ownership percentage. As a result, during the fourth quarter of 2018 the Company began accounting for its investment in Mobiquity as a marketable equity security. On May 10, 2019, the Company entered into a Membership Interest Purchase Agreement with Glen pursuant to which the Company acquired 49% of the membership interest in Advangelists, LLC (the “AVNG Interest”) in consideration of the assumption of a Promissory Note payable by Glen to the former owners of the AVGN Interest with an outstanding balance of $7,475,000 (the “AVNG Note”) and cancellation of an outstanding Promissory Note payable by Glen to the Company in the amount of $1,200,000 originally issued on March 1, 2019. Concurrently, the Company entered into a Membership Interest Purchase Agreement with Mobiquity pursuant to which the Company sold the AVNG Interest to Mobiquity in consideration of Mobiquity assuming the AVNG Note and Mobiquity amending the terms of the Remaining Mobiquity Warrant providing for cashless exercise. The Company paid 60,000,000 of its Mobiquity shares as partial consideration for the purchase of GBT Technologies, S. A. (see Note 5). On August 6, 2019, Mobiquity delivered a counter signed letter agreement dated August 2, 2019 pursuant to which the Company exchanged 120,000,000 Mobiquity Warrants into 20,000,000 shares of Mobiquity common stock, which resulted in the Company holding 60,000,000 shares of Mobiquity common stock. On September 10, 2019, the Company entered into (i) a Stock Purchase Agreement with Mobiquity pursuant to which the Company agreed to return 15,000,000 shares of Mobiquity common stock to Mobiquity in exchange for 110,000 shares of common stock of the Company, (ii) a Stock Purchase Agreement with Marital Trust GST Subject U/W/O Leopold Salkind (“Salkind Trust”) pursuant to which the Company agreed to sell 7,000,000 shares of Mobiquity common stock to Salkind Trust in consideration of $67,200, (iii) Stock Purchase Agreement with Dr. Gene Salkind (“Salkind”) pursuant to which the Company agreed to sell 28,000,000 shares of Mobiquity common stock to Salkind in consideration of $268,000 and (iv) a Stock Purchase Agreement with Deepanker Katyal (“Katyal”) pursuant to which the Company agreed to sell 10,000,000 shares of Mobiquity common stock to Katyal in consideration of 90,000 shares of common stock of the Company. The closing of the agreements occurred on September 13, 2019. As a result of these transactions, the Company realized a loss on the sale of Mobiquity common stock of $3,673,595. At December 31, 2020 and December 31, 2019, the Company owned no shares of Mobiquity common stock.

Equity Investment in GBT Techno

Equity Investment in GBT Technologies, S.A.	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Equity Investment in GBT Technologies, S.A.	Note 5 – Equity Investment in GBT Technologies, S.A. On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez in exchange for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note in the principal amount of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as the transfer and assignment of a Promissory Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity) and 60,000,000 restricted shares of common stock of Mobiquity. The Gopher Convertible Note bears interest of 6% per annum and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10.00 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. Upon conversion of the Gopher Convertible Note and the 20,000 shares of Series H Preferred Stock, Gonzalez would be entitled to less than 50% of the resulting outstanding shares of common stock of the Company following conversion in full and, as a result, such transaction is not considered a change of control. GBT-CR is in the business of the strategic management of BPO (Business Process Outsourcing) digital communications processing for enterprises and startups, distributed ledger technology development, AI development and fintech software development and applications. The Company accounted for its investment in GBT-CR using the equity method of accounting; however, in 2020, the Company owned less than 20% of and exercised no control over GBT-CR; therefore, this investment is currently accounted for under the cost method. Moreover, on March 19, 2020, California Governor Gavin Newsom issued a stay at home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). The stay at home order was lifted in California only on January 25, 2021. As such, the Company was unable to access or to contact GBT-CR on an on-going basis, and cannot get information about GBT-CR. At December 31, 2019, the Company evaluated the carrying amount of this equity investment and determined that this investment was fully impaired and as a result an impairment charge of $30,731,534 was taken.

Investment in Joint Venture

Investment in Joint Venture	12 Months Ended
	Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Investment in Joint Venture	Note 6 – Investment in Joint Venture On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 100,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services in consideration of $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the Tokenize Agreement occurred on March 9, 2020. Via this Joint Venture the parties commenced development of a development of an intelligent human vital signs’ device, suggested named qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps. At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $5,500,000 was taken. Although the investment was impaired, the product development is still ongoing.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Note 7 – Accounts Payable and Accrued Expenses Accounts payable and accrued expenses at December 31, 2020 and 2019 consist of the following: 2020 2019 Accounts payable $ 1,045,778 $ 535,481 Accrued interest 1,876,005 980,034 Deposits 249,675 249,094 Other 182,200 50,000 $ 3,353,658 $ 1,814,609

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2020
Notes Payable [Abstract]
Convertible Notes Payable	Note 8 – Convertible Notes Payable Convertible notes payable at December 31, 2020 and 2019 consist of the following: December 31, December 31, 2020 2019 Convertible note payable to GBT Technologies $ 10,000,000 $ 10,000,000 Convertible note payable to Glen Eagle - 1,000,000 Convertible note payable to Power Up - - Convertible notes payable to Redstart Holdings 347,400 - Convertible note payable to Stanley Hills 1,009,469 - Convertible note payable to Iliad 2,431,841 - Total convertible notes payable 13,788,710 11,000,000 Unamortized debt discount (362,004 ) - Convertible notes payable 13,426,706 11,000,000 Less current portion (13,426,706 ) - Convertible notes payable, long-term portion $ - $ 11,000,000 $10,000,000 for GBT Technologies S. A. acquisition In accordance with the acquisition of GBT-CR the Company issued a convertible note in the principal amount of $10,000,000. The convertible note bears interest of 6% per annum and is payable at maturity on December 31, 2021. At the election of the holder, the convertible note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10.00 per share). The convertible note is convertible into common stock at a fixed price that was higher than the Company’s common stock on the date of grant, therefore, this convertible note does not contain a beneficial conversion feature. Due to stock split (See Note 1) the conversion feature is substantially not in the money. The parties are in negotiations to address the issue per the Note holder demands to mitigate its damages. There is no guarantee that the Company will be successful in resolving this issue. Glen Eagles Acquisition LP On July 8, 2019, the Company entered a Consulting Agreement with Glen Eagles Acquisition LP (“Glen”) as consultant to provide services in connection with the Company’s acquisition of 25% of GBT Technologies, S.A., a Costa Rican corporation (“GBT-CR”). Consultant will provide analysis, interaction with related professional and other services as requested by the Company to integrate and expand capabilities between GBT-CR and the Company. The Company shall pay Glen $1,000,000 through the issuance of a 6% Convertible Note. At the election of Glen, the Convertible Note can be converted into a maximum of 2,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10.00 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. In addition, the Company entered into an Amendment of a Common Stock Purchase Warrant held by Glen to acquire nine million shares of common stock that had been assigned to Glen by Guardian Patch LLC. Pursuant to the amendment, the Company agreed to provide that the Common Stock Purchase Warrant may be exercised on a cashless basis and provided a beneficial ownership limitation of 4.99%. On or about June 23, 2020, the Company and AltCorp entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) into series of agreements regarding the $4,000,000 SURG Note. (See Note 4) Glen converted in full its $1,000,000 convertible note that was issued by the Company on July 8, 2019 plus $50,000 of accrued interest, into $1,050,000 of a SURG Note via an assignment of a portion ($1,050,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. In addition, the Company entered into a consulting agreement with Glen for which the Company shall pay to Glen $200,000 via an assignment of a portion ($200,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. Glen in turn will convert all its $1,250,000 considerations received into 2,500,000 SURG shares (See Note 17). Power Up Lending Group Ltd. On February 18, 2020, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd., an accredited investor (“Power Up”) pursuant to which the Company issued to Power Up a Convertible Promissory Note (the “Power Note”) in the aggregate principal amount of $183,600 for a purchase price of $153,000. The Power Note has a maturity date of May 15, 2021 and the Company has agreed to pay interest on the unpaid principal balance of the Power Note at the rate of six percent (6%) per annum from the date on which the Power Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Power Note, provided it makes a payment including a prepayment to Power Up as set forth in the Power Note. The transactions described above closed on February 19, 2020. The outstanding principal amount of the Power Note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Power Up may convert the Power Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 15-day look back immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Power Note), the Power Note shall become immediately due and payable and the Company shall pay to Power Up, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Power Note. During 2020, the full amount of the Power Note ($183,600) plus $4,590 of accrued interest was converted into shares of the Company’s common stock. Redstart Holdings Corp. On August 4, 2020, the Company entered into a Securities Purchase Agreement with Redstart Holdings Corp., an accredited investor (“Redstart”) pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 1”) in the aggregate principal amount of $153,600 for a purchase price of $128,000. The Redstart Note No. 1 has a maturity date of November 3, 2021 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note No. 1 at the rate of six percent (6%) per annum from the date on which the Redstart Note No. 1 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 1, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 1. The transactions described above closed on August 5, 2020. The outstanding principal amount of the Redstart Note No. 1 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180 th On September 15, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 2”) in the aggregate principal amount of $93,600 for a purchase price of $78,000. The Redstart Note No. 2 has a maturity date of September 15, 2021 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note No. 2 at the rate of six percent (6%) per annum from the date on which the Redstart Note No. 2 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 2, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 2. The transactions described above closed on September 16, 2020. The outstanding principal amount of the Redstart Note No. 2 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180 th On December 9, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 3”) in the aggregate principal amount of $100,200 for a purchase price of $83,500. The Redstart Note No. 3 has a maturity date of December 9, 2021 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note No. 3 at the rate of six percent (6%) per annum from the date on which the Redstart Note No. 3 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 3, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 3. The transactions described above closed on December 11, 2020. The outstanding principal amount of the Redstart Note No. 3 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180 th Stanley Hills LLC The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) since May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley (See Note 9) in the amount of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley has agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During 2020, Stanley converted $583,889 of its convertible note into 67,282,583 shares of the Company’s common stock, and during 2020, Stanley loaned the Company an additional $547,097. The balance of the Stanley debt at December 31, 2020 was $1,009,469. The Stanley debt is secured via a pledge agreement on the SURG shares (See Note 4). Iliad Research and Trading, L.P. On February 27, 2019, the Company entered into a note purchase agreement with a third-party investor - Iliad Research and Trading, L.P.(“Iliad”), pursuant to which the Company issued a promissory note for the original principal amount of $2,325,000. The promissory note had an original issue discount of $300,000 and the inventor paid consideration of $2,025,000 to the Company, of which $25,000 was paid for legal expenses. The outstanding balance of the promissory note is to be paid on the one-year anniversary of the issuance of the note. Interest on the note accrues at the rate of 10% per annum compounding daily. Subject to the terms and conditions set forth in the note, the Company may prepay all or any portion of the outstanding balance of the note at any time in an amount in cash equal to 120% of the amount repaid. In connection with transactions that generate less than $1,000,000 in proceeds, the Company has agreed to not issue any debt instrument or incurrence of any debt other than trade payables in the ordinary course of business, any securities or agreements to sell common stock with anti-dilution or price reset/reduction features or any securities that are or may be become convertible or exercisable into common stock with a price that varies with the market price of the common stock (collectively, “Restricted Issuance Transaction”). The outstanding balance of the Note will be increased by 5% in the event the Company enters into a Restricted Issuance Transaction that is approved by Iliad. The original issue discount is being amortized to interest expense over the term of the promissory note. On February 27, 2020, the Company and Iliad entered into an Amendment to the Iliad Note (See Note 9) pursuant to which the maturity date of the Iliad Note was extended to August 27, 2020, provided that the Debt may be converted into shares of common stock of the Company at a conversion price equal to 80% multiplied by the lowest trading daily VWAP for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date, provided for the payment by the Company to Iliad of an extension fee equal to 7.5% of the outstanding balance of the Iliad Note resulting in a new balance of the Iliad Note of $2,765,983 and provided that the Company’s failure to deliver shares of common stock within three trading days of a conversion would result in an event of default. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Iliad has agreed to restrict its ability to convert the Iliad Note and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 9.99% of the then issued and outstanding shares of common stock. On July 20, 2020 the Company and Iliad entered into agreement to extend the maturity of the Iliad Note until February 27, 2021 in consideration of an extension fee of $1,000. During 2020, Iliad converted $539,000 of its convertible note to 53,175,795 shares of the Company’s common stock. The balance of the Iliad debt at December 31, 2020 was $2,446,746, including accrued interest of $14,905. (See Note 17 for additional extension of this note) Discounts on convertible notes The Company recognized interest expense of $4,149,879 and $6,569,124 during the years ended December 31, 2020 and 2019, respectively, related to the amortization of the debt discount on convertible notes. The unamortized debt discount at December 31, 2020 was $362,004. A roll-forward of the convertible notes payable and debt discount from December 31, 2018 to December 31, 2020 is below: Principal Debt Balance Discount Net Convertible notes payable, December 31, 2018 $ 3,431,200 $ (3,233,124 ) $ 198,076 Issued for cash 3,000,000 — 3,000,000 Issued for acquisition 10,000,000 — 10,000,000 Issued for services 1,000,000 — 1,000,000 Original issue discount 336,000 — 336,000 Conversion to common stock (1,357,200 ) — (1,357,200 ) Debt discount related to new convertible notes — (3,336,000 ) (3,336,000 ) Reduction in convertible note due to legal settlement (5,410,000 ) — (5,410,000 ) Amortization of debt discounts — 6,569,124 6,569,124 Convertible notes payable, December 31, 2019 11,000,000 — 11,000,000 Issued for cash 820,958 — 820,958 Accrued interest added to convertible note 204,858 — 204,858 Exchange of convertible note for other company assets (1,000,000 ) — (1,000,000 ) Notes payable converted to convertible notes 3,980,883 — 3,980,883 Original issue discount 88,500 — 88,500 Conversion to common stock (1,306,489 ) — (1,306,489 ) Debt discount related to new convertible notes — (4,511,883 ) (4,511,883 ) Amortization of debt discounts — 4,149,879 4,149,879 Convertible notes payable, December 31, 2020 $ 13,788,710 $ (362,004 ) $ 13,426,706

Note Payable

Note Payable	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Note Payable	Note 9 – Notes Payable Notes payable at December 31, 2020 and December 31, 2019 consist of the following: December 31, December 31, 2020 2019 RWJ acquisition note $ 2,600,000 $ 2,600,000 Promissory note to Iliad - 2,325,000 Promissory note to Stanley Hills - 1,046,261 SBA loan 150,000 - Promissory note to Alpha Eda 140,000 - Total notes payable 2,890,000 5,971,261 Unamortized debt discount - (47,671 ) Notes payable 2,890,000 5,923,590 Less current portion (2,741,737 ) - Notes payable, long-term portion $ 148,263 $ 5,923,590 RWJ Acquisition Note In connection with the acquisition of RWJ in September 2017, the Company issued a note payable. The note accrues interest at 3.5% per annum, was due on December 31, 2019 and is secured by the assets purchased in the acquisition. The Company contests the validity of the note, as such the note has not been repaid as of December 31, 2020. (See Note 15). The balance of the note at December 31, 2020 is $2,600,000 plus accrued interest of $307,631. SBA Loan On June 22, 2020, the Company received a loan from the Small Business Administration under the Economic Injury Disaster Loan program related to the COVID-19 relief efforts. The loan bears interest at 3.75% per annum, requires monthly principal and interest payments of $731 after 12 months from funding and is due 30 years from the date of issuance. The balance of the note at December 31, 2020 is $150,000 plus accrued interest of $3,067. Alpha Eda On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC for $140,000. The note accrues interest at 10% per annum, is unsecured and is due on June 30, 2021. The balance of the note at December 31, 2020 is $140,000 plus accrued interest of $1,803. Iliad On February 27, 2019, the Company entered into a note purchase agreement with a third-party investor, pursuant to which the Company issued a promissory note for the original principal amount of $2,325,000. The promissory note had an original issue discount of $300,000 and the inventor paid consideration of $2,025,000 to the Company, of which $25,000 was paid for legal expenses. The outstanding balance of the promissory note is to be paid on the one-year anniversary of the issuance of the note. Interest on the note accrues at the rate of 10% per annum compounding daily. Subject to the terms and conditions set forth in the note, the Company may prepay all or any portion of the outstanding balance of the note at any time in an amount in cash equal to 120% of the amount repaid. In connection with transactions that generate less than $1,000,000 in proceeds, the Company has agreed to not issue any debt instrument or incurrence of any debt other than trade payables in the ordinary course of business, any securities or agreements to sell common stock with anti-dilution or price reset/reduction features or any securities that are or may be become convertible or exercisable into common stock with a price that varies with the market price of the common stock (collectively, “Restricted Issuance Transaction”). For every Restricted Issuance Transaction that the Company was funded during 2020, Iliad consent and approval was obtained. The outstanding balance of the Note will be increased by 5% in the event the Company enters into a Restricted Issuance Transaction that is approved by Iliad. The original issue discount in being amortized to interest expense over the term of the promissory note. On February 27, 2020, the Company and Iliad entered to an Amendment to the Iliad Note pursuant to which the maturity date of the Iliad Note was extended to August 27, 2020, provided that the Debt may be converted into shares of common stock of the Company at a conversion price equal to 80% multiplied by the lowest trading daily VWAP for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date, provided for the payment by the Company to Iliad of an extension fee equal to 7.5% of the outstanding balance of the Iliad Note resulting in a new balance of the Iliad Note of $2,765,983 which has been reclassified to convertible notes payable. (See Note 8). On July 20, 2020 the Company and Iliad entered into agreement to extend the maturity of the Iliad Note until February 27, 2021 in consideration of an extension fee of $1,000. During 2020, Iliad converted $539,000 of its convertible note to 53,175,795 shares of the Company’s common stock. The balance of the Iliad debt at December 31, 2020 was $$2,446,746, including accrued interest of $14,905. (See Note 17 for additional extension of this note) Stanley Hills The Company issued promissory notes with Stanley Hills for funds received as working capital. The notes accrue interest at 10% per annum and were due on February 9, 2020. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement (See Note 8) providing that the debt in the amount of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date. The Stanley Hills note was reclassified from notes payable to convertible notes payable (See Note 8). Discounts on Promissory Note The Company recognized interest expense of $47,671 and $252,329 during the years ended December 31, 2020 and 2019, respectively, related to the amortization of the debt discount on promissory notes. The unamortized debt discount at December 31, 2020 was $0. A roll-forward of the promissory notes and debt discount from December 31, 2018 to December 31, 2020 is below: Principal Debt Balance Discount Net Notes payable, December 31, 2018 $ 2,699,256 $ — $ 2,699,256 Issued for cash 3,071,261 — 3,071,261 Original issue discount 300,000 — 300,000 Repayment of note payable (99,256 ) — (99,256 ) Debt discount related to new convertible notes — (300,000 ) (300,000 ) Amortization of debt discounts — 252,329 252,329 Notes payable, December 31, 2019 5,971,261 (47,671 ) 5,923,590 Issued for cash 458,639 — 458,639 Accrued interest and penalties added to notes payable 440,983 — 440,983 Notes payable converted to convertible notes (3,980,883 ) — (3,980,883 ) Amortization of debt discounts — 47,671 47,671 Notes payable, December 31, 2020 $ 2,890,000 $ — $ 2,890,000

Accrued Settlement

Accrued Settlement	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Accrued Settlement	Note 10 – Accrued Settlement In connection with a legal matter filed by the Investor of the $8,340,000 Senior Secured Redeemable Convertible Debenture, on December 23, 2019, in the pending arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Senior Secured Redeemable Convertible Debenture (the “Debenture”) constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $4,034,444 plus interest of 7.25% accrued from May 15, 2019 (presented separately in accounts payable and accrued expenses) and costs in the amount of $55,613. (See Note 15). In connection with this settlement, the Company recognized a gain on the settlement of debt of $1,375,556 in 2019 as the difference between the carrying amount of the debt and the amount awarded by the arbitrator (See Note 15).

Derivative Liability

Derivative Liability	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Derivative Liability	Note 11 – Derivative Liability Certain of the convertible notes payable discussed in Note 8 have a conversion price that can be adjusted based on the Company’s stock price which results in the conversion feature being recorded as a derivative liability. The fair value of the derivative liability is recorded and shown separately under current liabilities. Changes in the fair value of the derivative liability is recorded in the statement of operations under other income (expense). The Company uses a weighted average Black-Scholes option pricing model with the following assumptions to measure the fair value of derivative liability at December 31, 2020 and 2019: December 31, December 31, 2020 2019 Stock price $ 0.017 $ 3.080 Risk free rate 0.10% 1.75% Volatility 275% 650% Conversion/ Exercise price $ .008-.0085 $ 0.800 Dividend rate 0% 0% The following table represents the Company’s derivative liability activity for the years ended December 31, 2019 and 2020: Derivative liability balance, December 31, 2018 $ 3,833,506 Issuance of derivative liability during the period 5,721,939 Fair value of beneficial conversion feature of debt converted (2,264,578 ) Change in derivative liability during the period (7,290,867 ) Derivative liability balance, December 31, 2019 - Issuance of derivative liability during the period 5,767,230 Fair value of beneficial conversion feature of debt converted (2,038,392 ) Change in derivative liability during the period 1,533,610 Derivative liability balance, December 31, 2020 $ 5,262,448

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 12 – Stockholders’ Equity Common Stock The Board of Directors of the Company approved, on April 13, 2020, a reverse stock split of all of the Company’s Common Stock, pursuant to which every 50 shares of Common Stock of the Company shall be reverse split, reconstituted and converted into one (1) share of Common Stock of the Company (the “Reverse Stock Split”). The Company submitted an Issuer Company Related Action Notification regarding the Reverse Stock Split to FINRA on April 14, 2020. To effectuate the Reverse Stock Split, the Company filed on April 21, 2020 a Certificate of Change Pursuant to Nevada Revised Statutes (“NRS”) Section 78.209 (the “Certificate of Change”) with the Secretary of State of the State of Nevada subject to FINRA approval. Since this reverse stock split has not yet been approved by the State of Nevada, the financial statements have not been retroactively restated to reflect this reverse stock split. On June 8, 2020 FINRA advised the Company that such request is deficient due to the fact that a holder of an outstanding convertible note of the Company had entered into two settlements with the Securities and Exchange Commission that related to securities laws violations but were in no way related to the Company. As a result, FINRA advised that it is necessary for the protection of investors, the public interest, and to maintain fair and orderly markets that documentation related to the Reverse Stock Split not be processed. The Company appealed the decision made by FINRA on June 15, 2020. On August 4, 2020, FINRA notified the Company that its appeal had been denied. During the year ended December 31, 2020, the Company had the following transactions in its common stock: ● issued an aggregate of 140,138,107 for the conversion of convertible notes of $1,306,489 and accrued interest of $4,590; and ● issued 100,000,000 shares to GBT Tokenize for a joint venture agreement. The value of the common stock of $5,500,000 was determined based on the closing stock price of the Company’s common stock on the grant date. During the year ended December 31, 2019, the Company had the following transactions in its common stock: ● issued an aggregate of 9,500 shares to employees and board members as part of their compensation agreements with the Company. The value of the common stock of $235,900 was determined based on the closing stock price of the Company’s common stock on the grant date; ● issued 74,762 shares to an investor for the conversion of $1,357,200 in convertible notes and $62,934 in accrued interest; ● issued 59,820 shares to an investor for disputed penalties on a convertible debenture. The value of the common stock of $975,065 was determined based on the closing stock price of the Company’s common stock on the grant date; ● issued 200,267 shares to Latinex in order to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has recorded the value ($7,610,147) of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. The value of the common stock was determined based on the closing stock price of the Company’s common stock on the grant date; ● issued 10,000,000 shares in connection with a joint venture with BitSpeed. The value of the common stock of $17,900,000 was based on the closing price of the Company’s common stock on the closing date; ● issued 4,566,214 shares in connection with the cashless exercise of 6,120,000 warrants; and ● canceled 200,000 shares that were returned in connection with the Company’s sale of its investment with Mobiquity. (See Note 4). The shares were valued based on the Company’s stock price on the date of the agreement. Series B Preferred Shares On November 1, 2011, the Company and certain creditors entered into a Settlement Agreement (the “Settlement Agreement”) whereby without admitting any wrongdoing on either part, the parties settled all previous agreements and resolved any existing disputes. Under the terms of the Settlement Agreement, the Company agreed to issue the creditors 45,000 shares of Series B Preferred Stock of the Company on a pro-rata basis. Following the issuance and delivery of the shares of Series B Preferred Stock to said creditors, as well as surrendering the undelivered shares, the Settlement Agreement resulted in the settlement of all debts, liabilities and obligations between the parties. The Series B Preferred Stock has a stated value of $100 per share and is convertible into the Company’s common stock at a conversion price of $30.00 per share representing 30 posts split common shares. Furthermore, the Series B Preferred Stock votes on an as converted basis and carries standard anti-dilution rights. These rights were subsequently removed, except in cases of stock dividends or splits. As of December 31, 2020, and 2019, there were 45,000 Series B Preferred Shares outstanding. Series C Preferred Shares On April 29, 2011, GV Global Communications, Inc. (“GV”) provided funding to the Company in the aggregate principal amount of $111,000 (the “Loan”). On September 25, 2012, the Company and GV entered into a Conversion Agreement pursuant to which the Company agreed to convert the Loan into 10,000 shares of Series C Preferred Stock of the Company, which was approved by the Board of Directors. Each share of Series C Preferred Stock is convertible, at the option of GV, into such number of shares of common stock of the Company as determined by dividing the Stated Value (as defined below) by the Conversion Price (as defined below). The Conversion Price for each share is equal to a 50% discount to the average of the lowest three lowest closing bid prices of the Company’s common stock during the 10-day trading period prior to the conversion with a minimum conversion price of $0.02. The stated value is $11.00 per share (the “Stated Value”). The Series C Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series C Preferred Stock shall be entitled to one vote for each share of common stock that the Series C Preferred Stock shall be convertible into. GV has contractually agreed to restrict its ability to convert the Series C Preferred Stock and receive shares of the Company’s common stock such that the number of shares of the Company’s common stock held by it and its affiliates after such conversion does not exceed 4.9% of the then issued and outstanding shares of the Company’s common stock. During the year ended December 31, 2014, GV Global Communications, Inc. converted 7,770 of its Series C Preferred Stock into 120 post-splits. During the third quarter of 2014, the Company received 42 post-split common shares to adjust the shares issued to reflect the amount that both they and the Company believed that they were owed. At December 31, 2020 and 2019, GV owns 700 Series C Preferred Shares. The issuance of the Series C Preferred Stock was made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 and Rule 506 promulgated under Regulation D thereunder. GV is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933. As of December 31, 2020, and 2019, there were 700 Series C Preferred Shares outstanding. Series D Preferred Shares As of December 31, 2020, and 2019, there are 0 and 0 shares of Series D Preferred Shares outstanding, respectively. Series G Preferred Shares As of December 31, 2020, and 2019, there are 0 and 0 shares of Series G Preferred Shares outstanding, respectively. Series H Preferred Shares On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez in exchange for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note in the principal amount of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as additional consideration. The Gopher Convertible Note bears interest of 6% per annum and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10.00 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. On July 8, 2019, the Company entered a Consulting Agreement with Glen Eagles Glen Eagles Acquisition LP (“Glen”) as consultant to provide services in connection with the Company’s acquisition of 25% of GBT-CR. Consultant will provide analysis, interaction with related professional and other services as requested by the Company to integrate and expand capabilities between GBT-CR and the Company. (See Note 14 for further details.) As of December 31, 2020, and 2019, there are 20,000 shares of Series H Preferred Shares outstanding. Warrants The following is a summary of warrant activity. Weighted Weighted Average Average Remaining Aggregate Warrants Exercise Contractual Intrinsic Outstanding Price Life Value Outstanding, December 31, 2018 419,167 $ 61.00 3.48 $ - Granted 25,355,000 0.97 Forfeited - Exercised (6,120,000 ) 0.50 Outstanding, December 31, 2019 19,654,167 $ 1.57 2.76 $ 1,111,600 Granted - Forfeited (10,667 ) 256.25 Exercised - Outstanding, December 31, 2020 19,643,500 $ 1.50 1.76 $ - Exercisable, December 31, 2020 19,643,500 $ 1.50 1.76 $ - The exercise price for warrant outstanding and exercisable at December 31, 2020: Outstanding Exercisable Number of Exercise Number of Exercise Warrants Price Warrants Price 15,880,000 $ 0.50 15,880,000 $ 0.50 3,000,000 1.85 3,000,000 1.85 500,000 2.70 500,000 2.70 20,000 31.90 20,000 31.90 100,000 50.00 100,000 50.00 75,000 75.00 75,000 75.00 50,000 100.00 50,000 100.00 10,000 235.00 10,000 235.00 7,500 250.00 7,500 250.00 1,000 280.00 1,000 280.00 19,643,500 19,643,500 The fair value of the warrants listed above was determined using the Black-Scholes option pricing model with the following assumptions: December 31, 2019 Risk-free interest rate 1.55% Expected life of the options 3.1 to 3.6 years Expected volatility 185% Expected dividend yield 0% As a result of the above-mentioned reverse stock split, the Company issued 25,245,000 warrants to purchase shares of the Company’s common stock with exercise prices ranging from $0.50 to $2.70 per share as a result of an anti-dilutive clause in certain of the Company’s outstanding warrants. The fair value of these warrants was $120,476,603 which is shown as a charge to earnings on the accompanying financial statements for the year ended December 31, 2019.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 13 – Income Taxes At December 31, 2020 and 2019, the significant components of the deferred tax assets are summarized below: December 31, December 31, 2020 2019 Deferred income tax asset Net operation loss carryforwards $ 8,232,796 $ 7,424,073 Total deferred income tax asset 8,232,796 7,424,074 Less: valuation allowance (8,232,796 ) (7,424,074 ) Total deferred income tax asset $ - $ - The valuation allowance increased by $808,722 and $1,606,154 in 2020 and 2019, respectively, as a result of the Company generating additional net operating losses. The Company’s net operating loss carryforward of approximately $28,390,000 begin to expire in 2024. No income tax expense reflected in the consolidated statements of income for the years 2020 and 2019. The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2020 and 2019 is as follows: 2020 2019 Amount Percent Amount Percent Federal statutory rates $ (3,757,564 ) 21.0 % $ (39,166,075 ) 21.0 % State income taxes (1,431,453 ) 8.0 % (14,920,410 ) 8.0 % Permanent differences 4,380,295 -24.5 % 52,480,331 -28.1 % Valuation allowance against net deferred tax assets 808,722 -4.5 % 1,606,154 -0.9 % Effective rate $ - 0.0 % $ - 0.0 % The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors. Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations. There were no interest or penalties accrued as of December 31, 2020 and 2019.

Related Parties

Related Parties	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Parties	Note 13 – Income Taxes At December 31, 2020 and 2019, the significant components of the deferred tax assets are summarized below: December 31, December 31, 2020 2019 Deferred income tax asset Net operation loss carryforwards $ 8,232,796 $ 7,424,074 Total deferred income tax asset 8,232,796 7,424,074 Less: valuation allowance (8,232,796 ) (7,424,074 ) Total deferred income tax asset $ — $ — The valuation allowance increased by $808,722 and $1,606,154 in 2020 and 2019, respectively, as a result of the Company generating additional net operating losses. The Company’s net operating loss carryforward of approximately $28,390,000 begin to expire in 2024. No income tax expense reflected in the consolidated statements of income for the years 2020 and 2019. The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2020 and 2019 is as follows: 2020 2019 Amount Percent Amount Percent Federal statutory rates $ (3,757,564 ) 21.0 % $ (39,166,075 ) 21.0 % State income taxes (1,431,453 ) 8.0 % (14,920,410 ) 8.0 % Permanent differences 4,380,295 -24.5 % 52,480,331 -28.1 % Valuation allowance against net deferred tax assets 808,722 -4.5 % 1,606,154 -0.9 % Effective rate $ - 0.0 % $ - 0.0 % The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors. Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations. There were no interest or penalties accrued as of December 31, 2020 and 2019.

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2020
Loss Contingency [Abstract]
Contingencies	Note 15 – Contingencies Legal Proceedings From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company. On or around January 30, 2019, RWJ Advanced Marketing, LLC, Greg Bauer, and Warren Jackson sued the Company and multiple third and related parties in Superior Court of the State of California - County of Los Angeles, General District in connection with the acquisition of UGO in September 2017. The case number is 19STCV03320 (the “Original Lawsuit”). The complaint in the Original Lawsuit alleges breach of contract, among other causes of action. The Company answered the complaint and filed a cross-complaint against the plaintiffs in the case and third parties on or around February 15, 2019. On or about September 10, 2020, the Company through its agent of service was “served” with a complaint (the Company contested service) that was recently filed against the Company and third parties by Robert Warren Jackson and Gregory Bauer in Los Angeles Superior Court Case No.: 20STCV32709 (“Second Lawsuit”). In the Original Lawsuit filed, the court rejected the plaintiff’s claims that they were filing a purported quasi-derivative lawsuit. As such, in this current litigation, the plaintiff is now again claiming the action is a derivative lawsuit. On October 13, 2020, the Second Lawsuit was removed by other defendants into Central District of California (CASE NO. 2:20−cv−09399−RGK−AGR). On February 2, 2021 The Central District of California dismissed the entire Second Lawsuit based on “demand futility”. In the Original lawsuit, the Company filed a cross complaint against the plaintiff and other third parties. Recently, the court has scheduled various hearings and a trial date set for December 27, 2021. It was the Company’s intention to dividend its holdings of its wholly owned subsidiary Ugopherservices Corp. (“UGO”). As UGO is the main dispute in the litigations described above, the Company has elected to sell UGO to a third-party effective July 1, 2020 (See Note 3). On September 17, 2020, the Company terminated Greg Bauer as consultant (resulting from the sale of UGO), which he confirmed in writing. Following the sale of UGO (See Note 3), the Company noticed third parties (including SURG, via its asset manager) to wire the UGO funds to its new bank account. SURG never answered the notice. The Company noticed certain third parties that it intends to take legal actions to resolve this issue. On November 12, 2020 the Company filed a complaint in the United States District Court – District of Nevada - Case 2:20-cv-02078 against RWJ, Mr. Bauer, Mr. Jackson and against W.L. Petrey Wholesale Company Inc for fraud, breach of contract, Unjust Enrichment and other claims. On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) in the aggregate face value of $8,340,000. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to 225,000 shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $100.00 per share with respect to 50,000 Warrant Shares, $75.00 with respect to 75,000 Warrant Shares and $50.00 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5.00 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5.00). The Market Price is the average of the 5 lowest individual daily volume weighted average prices during the period the Debenture is outstanding. On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $4,034,444 plus interest of 7.25% accrued from May 15, 2019 and costs in the amount of $55,613. On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the Final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorneys $48,844 and costs $716. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorneys $48,844 and costs $716 was denied. GBT Technologies, S.A. On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $300,000 which is nonrefundable. The Company has recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company in the amount of $5,000,000. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $200,000 to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. The $200,000 is recorded as unearned revenue at December 31, 2018 and reclassified to accrued expense at December 31, 2019. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded. In connection with SURG Exchange Agreement (see Note 4) - On November 4, 2020, Altcorp and Stanley filed an Ex Parte Motion In the District Court, Clark County, Nevada (Case No: A-20-823039-B, in Dep No: 43) to appoint receiver and issue a temporary restraining Order against SURG and its transfer agent for alleged defaults on prior exchange agreement. On December 4, 2020, the parties entered an interim agreement which set the material terms of the settlement. A final settlement was achieved per the interim agreement terms on January 1, 2021 (see Note 17). On March 4, 2021 the Company filed a motion to enforce settlement agreements, as the Company alleged that SURG owes an additional $240,000 which is due and owing under the settlement agreements.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2020
Risks and Uncertainties [Abstract]
Concentrations	Note 16 – Concentrations Concentration of Credit Risk Financial instruments, which potentially subject the Company to a concentration of credit risk, consist principally of temporary cash investments. There have been no losses in these accounts through December 31, 2020.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 17 – Subsequent Events Management has evaluated events that occurred subsequent to the end of the reporting period shown herein: On January 1, 2021 SURG, AltCorp and Stanley entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid via 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of SURG’s common stock during the ten (10) trading days immediately preceding the issuance. At the end of the 33rd month, if AltCorp has not realized gross, pre-tax proceeds at least equal to the amount of the Debt, SURG shall transfer to AltCorp and/or its designee additional shares of SURG’s common stock necessary to satisfy the Debt. To the date of this report, SURG has made three payments per the settlement agreements. On February 10, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 4”) in the aggregate principal amount of $184,200 for a purchase price of $153,500. The Redstart Note No. 4 has a maturity date of February 5, 2022 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note No. 4 at the rate of six percent (6%) per annum from the date on which the Redstart Note No. 4 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 4, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 4. The transactions described above closed on February 10, 2021. The outstanding principal amount of the Redstart Note No. 4 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180 th On March 15, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 5”) in the aggregate principal amount of $106,200 for a purchase price of $88,500. The Redstart Note No. 5 has a maturity date of June 15, 2022 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note No. 5 at the rate of six percent (6%) per annum from the date on which the Redstart Note No. 5 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 5, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 5. The transactions described above closed on March 17, 2021. The outstanding principal amount of the Redstart Note No. 5 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180 th On January 19, 2021 the Company entered into consulting agreements with two third-party consultants. The executive officers of the Company conducted an extensive search and has explored all possible avenues of financing and in order to fully-implement its business plan it has determined that for its best interest to engage two outside consultants to identify investors as an accredited investor, under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Private Offering”) is in the best interest of the Company. The terms of the agreements are for one consultant a 12,000,000 Company one-time new shares issuance and $1,000 cash monthly payment, and to the second consultant 250,000 Company one-time new shares issuance, along with additional 30,000 new issuance per quarter, and $500 cash monthly payment. The company issued to the consultants the 12,250,000 restricted stock on February 11, 2021. On February 28, 2021 the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until May 31, 2021 in consideration of an extension fee of $1,000 representing the third extension of the original note. (See Note 8) Subsequent to December 31, 2020, the Company issued 224,185,847 shares of common stock in exchange for $3,116,668 of convertible notes payable and $6,180 of accrued interest. Included in these amounts are the conversions of the Redstart Note No. 1 and Redstart Note No. 2)

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include valuation of derivatives and valuation allowance on deferred tax assets.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned AltCorp Trading LLC, a Costa Rica company (“AltCorp”) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich”). All significant intercompany transactions and balances have been eliminated.
Cash Equivalents	Cash Equivalents For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2020, and 2019, the Company did not have any cash equivalents.
Cash Held in Trust	Cash Held in Trust Cash held in trust consists of proceeds from the sale of investments. The proceeds less the payment of certain expenses are being held in AltCorp’s (the Company’s wholly owned subsidiary) attorney trust account. (See Note 4)
Long-Lived Assets	Long-Lived Assets The Company applies the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 360, Property, Plant, and Equipment
Marketable Equity Securities	Marketable Equity Securities The Company accounts for marketable equity securities in accordance with ASC Topic 321, Investments – equity securities.
Note Receivable	Note Receivable Note receivable consists of a promissory note received in connection with the sale of Ugopherservices (see Notes 3, 4 and 17). The note is due on December 31, 2021 and accrues interest at 6% per annum. At December 31, 2020, the Company determined that this note receivable was not collectible and took an impairment charge of $100,000.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2020, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion. During the year ended December 31, 2019, the convertible notes with embedded conversion features were settled; therefore, there was no derivative liability at December 31, 2019.
Fair Value of Financial Instruments	Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities. FASB ASC Topic 820, Fair Value Measurements and Disclosures Financial Instruments ● Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. ● Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the fair value measurement. The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity Derivatives and Hedging For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their fair values were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. At December 31, 2020 and 2019, the Company identified the following liabilities that are required to be presented on the balance sheet at fair value: Fair Value Fair Value Measurements at As of December 31, 2020 Description December 31, 2020 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Marketable equity security - Surge Holdings, Inc. $ 649,000 $ - $ 649,000 $ - Conversion feature on convertible notes $ 5,262,448 $ - $ 5,262,448 $ - Fair Value Fair Value Measurements at As of December 31, 2019 Description December 31, 2019 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Marketable equity security - Surge Holdings, Inc. $ 1,000,000 $ - $ 1,000,000 $ -
Treasury Stock	Treasury Stock Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital.
Stock Loan Receivable	Stock Loan Receivable On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has pledged 200,267 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for a term of three years in consideration of an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company has recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principal to return the pledged 200,267 restricted shares to the Company for cancellation. The 200,267 restricted shares have not yet been returned to the Company as of December 31, 2020.
Revenue Recognition	Revenue Recognition Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Topic 606 Topic 606. Topic 605, Revenue Recognition Revenue is recognized under Topic 606 ● executed contracts with the Company’s customers that it believes are legally enforceable; ● identification of performance obligations in the respective contract; ● determination of the transaction price for each performance obligation in the respective contract; ● allocation the transaction price to each performance obligation; and ● recognition of revenue only when the Company satisfies each performance obligation. These five elements, as applied to each of the Company’s revenue category, is summarized below: ● IT services - revenue is recorded on a monthly basis as services are provided; and ● License fees and Royalties – revenue is recognized based on the terms of the agreement with its customer.
Unearned revenue	Unearned revenue Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. In 2018, the Company ran pre-sales efforts for its pet tracker product and received prepayments for its product. In addition, during 2018, the Company received $200,000 in connection with an intellectual property license and royalty agreement. At December 31, 2019, the Company determined that the unearned revenue would not likely result in the recognition of revenue; therefore, $249,094 of unearned revenue was reclassified to accrued expenses at December 31, 2020 and 2019.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share December 31, December 31, 2020 2019 Series B preferred stock 30 30 Series C preferred stock 8 8 Series H preferred stock 1,000,000 1,000,000 Warrants 19,643,500 19,654,167 Convertible notes 481,351,062 1,100,000 Total 501,994,600 21,754,205
Management's Evaluation of Subsequent Events	Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of December 31, 2020, through the date which the consolidated financial statements are issued. Based upon the review, other than described in Note 17 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes Income Taxes Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Fair Value Measurements	At December 31, 2020 and 2019, the Company identified the following liabilities that are required to be presented on the balance sheet at fair value: Fair Value Fair Value Measurements at As of December 31, 2020 Description December 31, 2020 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Marketable equity security - Surge Holdings, Inc. $ 649,000 $ - $ 649,000 $ - Conversion feature on convertible notes $ 5,262,448 $ - $ 5,262,448 $ - Fair Value Fair Value Measurements at As of December 31, 2019 Description December 31, 2019 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Marketable equity security - Surge Holdings, Inc. $ 1,000,000 $ - $ 1,000,000 $ -
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive. December 31, December 31, 2020 2019 Series B preferred stock 30 30 Series C preferred stock 8 8 Series H preferred stock 1,000,000 1,000,000 Warrants 19,643,500 19,654,167 Convertible notes 481,351,062 1,100,000 Total 501,994,600 21,754,205

Discontinued Operations; Note_2

Discontinued Operations; Note Receivable (Tables)	12 Months Ended
	Dec. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	The operating results for UGO, ECS Prepaid, Electronic Check Services and the Central State Legal Services have been presented in the accompanying consolidated statements of operations for the years ended December 31, 2020 and 2019 as discontinued operations and are summarized below: Years Ended December 31, 2020 2019 Revenue $ 8,291,842 $ 42,998,336 Cost of revenue 7,900,122 41,596,118 Gross Profit 391,720 1,402,218 Operating expenses 408,644 2,477,084 Loss from operations (16,924 ) (1,074,866 ) Other income (expenses) - (3 ) Net loss $ (16,924 ) $ (1,074,869 ) The assets and liabilities of the discontinued operations at December 31, 2020 and 2019 are summarized below: December 31, December 31, 2020 2019 Current assets $ - $ 89,123 Property and equipment - 117,686 Total assets $ - $ 206,809 Current liabilities $ - $ 1,151,073 Total liabilities $ - $ 1,151,073

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Note 7 – Accounts Payable and Accrued Expenses Accounts payable and accrued expenses at December 31, 2020 and 2019 consist of the following: 2020 2019 Accounts payable $ 1,045,778 $ 535,481 Accrued interest 1,876,005 980,034 Deposits 249,675 249,094 Other 182,200 50,000 $ 3,353,658 $ 1,814,609

Equity Investment in GBT Tech_2

Equity Investment in GBT Technologies, S.A. (Tables)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Equity Investment Information regarding GBT-CR	Information regarding GBT-CR as of and for the year ended December 31, 2019 is below: Current assets $ 979,389 Total assets 7,013,772 Current liabilities 359,040 Total liabilities 2,645,706 Total stockholders' equity 4,368,066 Revenue $ 4,138,496 Operating expenses 3,103,691 Other expenses 398,501 Net income 636,304

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2020
Notes Payable [Abstract]
Summary of Convertible notes payable	Convertible notes payable at December 31, 2020 and 2019 consist of the following: December 31, December 31, 2020 2019 Convertible note payable to GBT Technologies $ 10,000,000 $ 10,000,000 Convertible note payable to Glen Eagle - 1,000,000 Convertible note payable to Power Up - - Convertible notes payable to Redstart Holdings 347,400 - Convertible note payable to Stanley Hills 1,009,469 - Convertible note payable to Iliad 2,431,841 - Total convertible notes payable 13,788,710 11,000,000 Unamortized debt discount (362,004 ) - Convertible notes payable 13,426,706 11,000,000 Less current portion (3,426,706 ) - Convertible notes payable, long-term portion $ 10,000,000 $ 11,000,000
Rollfoward of convertible note	A roll-forward of the convertible notes payable and debt discount from December 31, 2018 to December 31, 2020 is below: Principal Debt Balance Discount Net Convertible notes payable, December 31, 2018 $ 3,431,200 $ (3,233,124 ) $ 198,076 Issued for cash 3,000,000 — 3,000,000 Issued for acquisition 10,000,000 — 10,000,000 Issued for services 1,000,000 — 1,000,000 Original issue discount 336,000 — 336,000 Conversion to common stock (1,357,200 ) — (1,357,200 ) Debt discount related to new convertible notes — (3,336,000 ) (3,336,000 ) Reduction in convertible note due to legal settlement (5,410,000 ) — (5,410,000 ) Amortization of debt discounts — 6,569,124 6,569,124 Convertible notes payable, December 31, 2019 11,000,000 — 11,000,000 Issued for cash 820,958 — 820,958 Accrued interest added to convertible note 204,858 — 204,858 Exchange of convertible note for other company assets (1,000,000 ) — (1,000,000 ) Notes payable converted to convertible notes 3,980,883 — 3,980,883 Original issue discount 88,500 — 88,500 Conversion to common stock (1,306,489 ) — (1,306,489 ) Debt discount related to new convertible notes — (4,511,883 ) (4,511,883 ) Amortization of debt discounts — 4,149,879 4,149,879 Convertible notes payable, December 31, 2020 $ 13,788,710 $ (362,004 ) $ 13,426,706

Note Payable (Tables)

Note Payable (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Notes payable	Notes payable at December 31, 2020 and December 31, 2019 consist of the following: December 31, December 31, 2020 2019 RWJ acquisition note $ 2,600,000 $ 2,600,000 Promissory note to Iliad - 2,325,000 Promissory note to Stanley Hills - 1,046,261 SBA loan 150,000 - Promissory note to Alpha Eda 140,000 - Total notes payable 2,890,000 5,971,261 Unamortized debt discount - (47,671 ) Notes payable 2,890,000 5,923,590 Less current portion (2,741,737 ) - Notes payable, long-term portion $ 148,263 $ 5,923,590
Rollfoward of note payable	A roll-forward of the promissory notes and debt discount from December 31, 2018 to December 31, 2020 is below: Principal Debt Balance Discount Net Notes payable, December 31, 2018 $ 2,699,256 $ — $ 2,699,256 Issued for cash 3,071,261 — 3,071,261 Original issue discount 300,000 — 300,000 Repayment of note payable (99,256 ) — (99,256 ) Debt discount related to new convertible notes — (300,000 ) (300,000 ) Amortization of debt discounts — 252,329 252,329 Notes payable, December 31, 2019 5,971,261 (47,671 ) 5,923,590 Issued for cash 458,639 — 458,639 Accrued interest and penalties added to notes payable 440,983 — 440,983 Notes payable converted to convertible notes (3,980,883 ) — (3,980,883 ) Amortization of debt discounts — 47,671 47,671 Notes payable, December 31, 2020 $ 2,890,000 $ — $ 2,890,000

Derivative Liability (Tables)

Derivative Liability (Tables)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Assumptions to measure fair value	The Company uses a weighted average Black-Scholes option pricing model with the following assumptions to measure the fair value of derivative liability at December 31, 2020 and 2019: December 31, December 31, 2020 2019 Stock price $ 0.017 $ 3.080 Risk free rate 0.10% 1.75% Volatility 275% 650% Conversion/ Exercise price $ .008-.0085 $ 0.800 Dividend rate 0% 0%
Schedule of Derivative Liabilities at Fair Value	The following table represents the Company’s derivative liability activity for the years ended December 31, 2019 and 2020: Derivative liability balance, December 31, 2018 $ 3,833,506 Issuance of derivative liability during the period 5,721,939 Fair value of beneficial conversion feature of debt converted (2,264,578 ) Change in derivative liability during the period (7,290,867 ) Derivative liability balance, December 31, 2019 - Issuance of derivative liability during the period 5,767,230 Fair value of beneficial conversion feature of debt converted (2,038,392 ) Change in derivative liability during the period 1,533,610 Derivative liability balance, December 31, 2020 $ 5,262,448

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Summary of warrant activity	The following is a summary of warrant activity. Weighted Weighted Average Average Remaining Aggregate Warrants Exercise Contractual Intrinsic Outstanding Price Life Value Outstanding, December 31, 2018 419,167 $ 61.00 3.48 $ - Granted 25,355,000 0.97 Forfeited - Exercised (6,120,000 ) 0.50 Outstanding, December 31, 2019 19,654,167 $ 1.57 2.76 $ 1,111,600 Granted - Forfeited (10,667 ) 256.25 Exercised - Outstanding, December 31, 2020 19,643,500 $ 1.50 1.76 $ - Exercisable, December 31, 2020 19,643,500 $ 1.50 1.76 $ -
Summary of exercise price for warrant outstanding	The exercise price for warrant outstanding and exercisable at December 31, 2020: Outstanding Exercisable Number of Exercise Number of Exercise Warrants Price Warrants Price 15,880,000 $ 0.50 15,880,000 $ 0.50 3,000,000 1.85 3,000,000 1.85 500,000 2.70 500,000 2.70 20,000 31.90 20,000 31.90 100,000 50.00 100,000 50.00 75,000 75.00 75,000 75.00 50,000 100.00 50,000 100.00 10,000 235.00 10,000 235.00 7,500 250.00 7,500 250.00 1,000 280.00 1,000 280.00 19,643,500 19,643,500
Schedule of Assumptions	The fair value of the warrants listed above was determined using the Black-Scholes option pricing model with the following assumptions: December 31, 2019 Risk-free interest rate 1.55% Expected life of the options 3.1 to 3.6 years Expected volatility 185% Expected dividend yield 0%

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Components of deferred tax assets	At December 31, 2020 and 2019, the significant components of the deferred tax assets are summarized below: December 31, December 31, 2020 2019 Deferred income tax asset Net operation loss carryforwards $ 8,232,796 $ 7,424,074 Total deferred income tax asset 8,232,796 7,424,074 Less: valuation allowance (8,232,796 ) (7,424,074 ) Total deferred income tax asset $ — $ —
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2020 and 2019 is as follows: 2020 2019 Amount Percent Amount Percent Federal statutory rates $ (3,757,564 ) 21.0 % $ (39,166,075 ) 21.0 % State income taxes (1,431,453 ) 8.0 % (14,920,410 ) 8.0 % Permanent differences 4,380,295 -24.5 % 52,480,331 -28.1 % Valuation allowance against net deferred tax assets 808,722 -4.5 % 1,606,154 -0.9 % Effective rate $ - 0.0 % $ - 0.0 %

Organization and Nature of Busi

Organization and Nature of Business (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reverse stock split	1 for 100
Accumulated deficit	$ (270,651,339)	$ (252,656,451)
Working capital deficit	$ (27,710,040)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details 1) - Surge Holdings [Member] - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Marketable equity security	$ 649,000	$ 1,000,000
Conversion feature on convertible notes	5,262,448
Fair Value, Inputs, Level 1 [Member]
Marketable equity security
Conversion feature on convertible notes
Fair Value, Inputs, Level 2 [Member]
Marketable equity security	649,000	1,000,000
Conversion feature on convertible notes	5,262,448
Fair Value, Inputs, Level 3 [Member]
Marketable equity security
Conversion feature on convertible notes

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 2) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Convertible note	481,351,062	1,100,000
Number of potentially dilutive securities	501,994,600	21,754,205
Warrant [Member]
Number of potentially dilutive securities	19,643,500	19,654,167
Series B Convertible Preferred Stock [Member]
Preferred shares	30	30
Series C Convertible Preferred Stock [Member]
Preferred shares	8	8
Series H Convertible Preferred Stock [Member]
Preferred shares	1,000,000	1,000,000

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Jan. 08, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash equivalents		$ 0	$ 0
Impairment of long-lived assets		0	0
Derivative financial instruments		0	0
Number of restricted shares pledged	200,267
Value of restricted shares	$ 7,610,147
Unearned revenue		249,094	249,094
Uncertain tax positions		$ 0	$ 0
Cash received in connection with intellectual property license and royalty agreement				$ 200,000
Notes Receivable [Member]
Maturity date		Dec. 31, 2021
Interest rate		6.00%
Impairment charge		$ 100,000

Discontinued Operations; Note_3

Discontinued Operations; Note Receivable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expenses	$ 7,952,836	$ 176,637,100
Loss from operations	(7,772,836)	(176,457,100)
Other income (expenses)	(11,206,839)	(10,354,953)
Net loss	(17,994,888)	(186,505,119)
Discontinued Operations [Member]
Revenue	8,291,842	42,998,336
Cost of revenue	7,900,122	41,596,118
Gross Profit	391,720	1,402,218
Operating expenses	408,644	2,477,084
Loss from operations	(16,924)	(1,074,866)
Other income (expenses)	0	(3)
Net loss	$ (16,924)	$ (1,074,869)

Discontinued Operations; Note_4

Discontinued Operations; Note Receivable (Details 1) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets	$ 1,164,566	$ 1,266,443
Total assets	1,164,566	5,266,443
Current liabilities	28,874,606	12,979,329
Total liabilities	29,022,869	23,979,329
Discontinued Operations [Member]
Current assets	0	89,123
Property and equipment	0	117,686
Total assets	0	206,809
Current liabilities	0	1,151,073
Total liabilities	$ 0	$ 1,151,073

Discontinued Operations; Note_5

Discontinued Operations; Note Receivable (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 18, 2019	Dec. 31, 2020
Asset Purchase Agreement [Member] | Surge Holdings [Member]
Sale of common stock	3,333,333
Consideartion from sale of common stock	$ 5,000,000
Payment of principal	$ 4,000,000
Number of common stock pledged	3,333,333
Purchase and Sale Agreement [Member] | Mr. LightHouse LTD [Member]
Consideartion from sale of common stock		$ 100,000
Impairment charge			$ 100,000

Investment in. Surge Holdings,

Investment in. Surge Holdings, Inc. and Mobiquity Technologies, Inc.; Convertible Note Receivable (Details Narrative) - USD ($)	Sep. 10, 2019	Aug. 06, 2019	May 10, 2019	Sep. 04, 2018	Jun. 23, 2020	Sep. 30, 2019	Nov. 19, 2018	Dec. 31, 2020	Aug. 12, 2020	Dec. 31, 2019
Common stock shares authorised								100,000,000,000		100,000,000,000
Warrants description		Mobiquity delivered a counter signed letter agreement dated August 2, 2019 pursuant to which the Company exchanged 120,000,000 Mobiquity Warrants into 20,000,000 shares of Mobiquity common stock, which will result in the Company holding 60,000,000 shares of Mobiquity common stock.
Shares reserved for future issuance									5,500,000
Mobiquity [Member]
Number of restricted Series AAAA Preferred Stock received				1,000
Issuance of common stock				10,000,000			200
Number of shares converted				100,000,000			20,000,000
Common stock purchase warrants issued				150,000,000			30,000,000
Warrant exercise price				$ 0.12			$ 0.12
Term				5 years
Common stock shares authorised				250,000,000
Mobiquity [Member] | Stock Purchase Agreement [Member]
Issuance of common stock	110,000
Number of common stock returned	15,000,000
Loss on sale of common stock	$ 3,673,595
Mobiquity [Member] | Stock Purchase Agreement [Member] | Salkind Trust [Member]
Sale of common stock	7,000,000
Consideartion from sale of common stock	$ 67,200
Mobiquity [Member] | Stock Purchase Agreement [Member] | Salkind [Member]
Sale of common stock	28,000,000
Consideartion from sale of common stock	$ 268,000
Mobiquity [Member] | Stock Purchase Agreement [Member] | Katyal [Member]
Issuance of common stock	90,000
Common stock owned	0
Sale of common stock	10,000,000
Glen Eagles Acquisition LP [Member]
Common stock issued for consulting services							20,000
Surge Holdings [Member]
Convertible debt decription					On or about June 23, 2020, the Company and AltCorp entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) into series of agreements regarding the $4,000,000 SURG Note for which the SURG Note has been converted in full into 5,500,000 restricted stock of SURG (“Issued Shares”) along with an additional 22,000,000 SURG shares reserved for the benefit of the Company’s subsidiary as a true up of shares to secure the value of the Issued Shares as $2,750,000. The Company agreed that the Issued Shares will be restricted for a year. As a result of the exchange of $2,750,000 of the SURG Note for 5,500,000 shares of SURG common stock, the Company recognized a loss of $1,430,000.
Stock Issued During Period, Shares, Purchase of Assets								5,500,000
Stock Issued During Period, Value, Purchase of Assets								$ 649,000
Surge Holdings [Member] | Asset Purchase Agreement [Member]
Sale of common stock						3,333,333
Consideartion from sale of common stock						$ 5,000,000
Payment of principal						$ 4,000,000
Lawyer's trust [Member]
Accrued legal fees								$ 402,532
Advangelists, LLC [Member]
Membership interest			49.00%
Interest			$ 7,475,000
Promissory Note payable description			Cancellation of an outstanding Promissory Note payable by Glen to the Company in the amount of $1,200,000 originally issued on March 1, 2019.
GBT Technologies, S.A. [Member]
Payment of consideration								60,000,000

Equity Investment in GBT Tech_3

Equity Investment in GBT Technologies, S.A. (Details Narrative) - USD ($)	Feb. 06, 2019	Jun. 17, 2019	Dec. 31, 2020	Dec. 31, 2019
Conversion price (in dollars per share)				$ 0.800
Debt conversion, converted instrument, Value			$ 1,306,489
Impairment charge			$ 5,600,000	$ 48,631,534
Altcorp [Member]
Note payable description	Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity) and 60,000,000 restricted shares of common stock of Mobiquity.
Impairment charge				$ 30,731,534
Altcorp [Member] | Series H Convertible Preferred Stock [Member]
Number of shares converted		20,000
Stock Issued for Acquisitions, Shares		625,000
Conversion price (in dollars per share)		$ 10
Debt conversion, converted instrument, Value		$ 10,000,000
Interest rate		6.00%
Maturity date		Dec. 31, 2021
Dividend per share		$ 500

Investment in Joint Venture (De

Investment in Joint Venture (Details Narrative) - USD ($)	Mar. 06, 2020	Dec. 31, 2020	Dec. 31, 2019
Impairment charge		$ 5,600,000	$ 48,631,534
Tokenize Agreement
Common stock contributed	100,000,000
Greenwich [Member] | Tokenize Agreement
Common stock contributed	100,000,000
Services in consideration	$ 33,333
Impairment charge		$ 5,500,000

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Related Party Transactions [Abstract]
Accounts payable	$ 1,045,778	$ 535,481
Accrued interest	1,876,005	980,034
Deposits	249,675	249,094
Other	182,200	50,000
Accounts Payable and Accrued Expenses	$ 3,353,658	$ 1,814,609

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Total convertible notes payable	$ 13,788,710	$ 11,000,000
Unamortized debt discount	(362,004)	0
Convertible note payable	13,426,706	11,000,000
Less current portion	(13,426,706)
Convertible notes payable, long-term portion		11,000,000
GBT Technologies, S.A. [Member]
Total convertible notes payable	10,000,000	10,000,000
Glen Eagle [Member]
Total convertible notes payable		1,000,000
Power Up [Member]
Total convertible notes payable
Redstart Holdings [Member]
Total convertible notes payable	347,400
Stanley Hills [Member]
Total convertible notes payable	1,009,469
Iliad [Member]
Total convertible notes payable	$ 2,431,841

Convertible Notes Payable (De_2

Convertible Notes Payable (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Convertible notes payable, at beginning	$ 11,000,000
Debt discount at beginning	(47,671)
Amortization of debt discounts	4,197,550	$ 6,821,453
Debt discount at end	0	(47,671)
Convertible notes payable, at end	13,426,706	11,000,000
Convertible Notes Payable 2 ("Power Up Lending Group Ltd") [Member]
Convertible notes payable, at beginning	11,000,000	198,076
Issued for cash	820,958	3,000,000
Issued for acquisition		10,000,000
Issued for services		1,000,000
Accrued interest added to convertible note	204,858
Exchange of convertible note for other company assets	(1,000,000)
Notes payable converted to convertible notes	3,980,883
Original issue discount	88,500	336,000
Conversion to common stock	(1,306,489)	(1,357,200)
Debt discount related to new convertible notes	(4,511,883)	(3,336,000)
Reduction in convertible note due to legal settlement		(5,410,000)
Amortization of debt discounts	4,149,879	6,569,124
Convertible notes payable, at end	13,426,706	11,000,000
Convertible Notes Payable 2 ("Power Up Lending Group Ltd") [Member] | Principal [Member]
Convertible notes payable, at beginning	11,000,000	3,431,200
Issued for cash	820,958	3,000,000
Issued for acquisition		10,000,000
Issued for services		1,000,000
Accrued interest added to convertible note	204,858
Exchange of convertible note for other company assets	(1,000,000)
Notes payable converted to convertible notes	3,980,883
Original issue discount	88,500	336,000
Conversion to common stock	(1,306,489)	(1,357,200)
Debt discount related to new convertible notes
Reduction in convertible note due to legal settlement		(5,410,000)
Amortization of debt discounts
Convertible notes payable, at end	13,788,710	11,000,000
Convertible Notes Payable 2 ("Power Up Lending Group Ltd") [Member] | Debt Discount [Member]
Debt discount at beginning		(3,233,124)
Issued for cash
Issued for acquisition
Issued for services
Accrued interest added to convertible note
Exchange of convertible note for other company assets
Notes payable converted to convertible notes
Original issue discount
Conversion to common stock
Debt discount related to new convertible notes	(4,511,883)	(3,336,000)
Reduction in convertible note due to legal settlement
Amortization of debt discounts	4,149,879	6,569,124
Debt discount at end	$ (362,004)

Convertible Notes Payable (De_3

Convertible Notes Payable (Detail Narrative) - USD ($)	Dec. 09, 2020	Aug. 04, 2020	Sep. 15, 2020	Jul. 20, 2020	Jun. 23, 2020	Feb. 27, 2020	Feb. 18, 2020	Jun. 17, 2019	Feb. 27, 2019	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Conversion price (in dollars per share)												$ 0.800
Value of share converted											$ 1,306,489
Amortization of debt discount											4,197,550	$ 6,821,453
Unamortized debt discount										$ 0	0	47,671
Convertible note payable										13,788,710	13,788,710	11,000,000
Convertible Notes Payable
Debt Instrument [Line Items]
Original issue discount											88,500	336,000
Amortization of debt discount											4,149,879	6,569,124
Unamortized debt discount										362,004	362,004
Convertible note payable										13,426,706	13,426,706
Promissory Note [Member]
Debt Instrument [Line Items]
Note payable, principal amount									$ 2,325,000
Original issue discount									300,000
Consideration									2,025,000
Paid for legal fees									25,000
Securities Purchase Agreement | Convertible Notes Payable
Debt Instrument [Line Items]
Note payable, principal amount							$ 183,600
Note payable, interest rate							6.00%
Note maturity date							May 15, 2021
Purchase price							$ 153,000
Iliad [Member]
Debt Instrument [Line Items]
Value of share converted											$ 539,000
Number of shares converted											53,175,795
Convertible note payable										2,431,841	$ 2,431,841
Accrued interest										14,905	14,905
Iliad [Member] | Securities Purchase Agreement
Debt Instrument [Line Items]
Note payable, principal amount						$ 2,765,983				2,446,746	$ 2,446,746
Note maturity date						Aug. 27, 2020
Maturity date extension fees				$ 1,000
Number of shares converted											53,175,795
Accrued interest										14,905	$ 14,905
Stanley [Member]
Debt Instrument [Line Items]
Note payable, principal amount									$ 1,214,900	1,009,469	1,009,469
Proceeds from related party debt										547,097
Note maturity date									Feb. 9, 2020
Value of share converted											$ 583,889
Number of shares converted											67,282,583
Altcorp [Member] | Series H Convertible Preferred Stock [Member]
Debt Instrument [Line Items]
Conversion price (in dollars per share)								$ 10
Note maturity date								Dec. 31, 2021
Value of share converted								$ 10,000,000
Number of shares converted								20,000
Surge Holdings [Member]
Debt Instrument [Line Items]
Convertible debt decriptions					On or about June 23, 2020, the Company and AltCorp entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) into series of agreements regarding the $4,000,000 SURG Note. (See Note 4) Glen converted in full its $1,000,000 convertible note that was issued by the Company on July 8, 2019 plus $50,000 of accrued interest, into $1,050,000 of a SURG Note via an assignment of a portion ($1,050,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. In addition, the Company entered into a consulting agreement with Glen for which the Company shall pay to Glen $200,000 via an assignment of a portion ($200,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. Glen in turn will convert all its $1,250,000 considerations received into 2,500,000 SURG shares
Redstart Holdings Corp [Member] | Securities Purchase Agreement
Debt Instrument [Line Items]
Note payable, principal amount	$ 100,200	$ 153,600	$ 93,600
Note payable, interest rate	6.00%	6.00%	6.00%
Note maturity date	Dec. 9, 2021	Nov. 3, 2021	Sep. 15, 2021
Purchase price	$ 83,500	$ 128,000	$ 78,000
Power Up [Member]
Debt Instrument [Line Items]
Convertible note payable
Power Up [Member] | Securities Purchase Agreement
Debt Instrument [Line Items]
Note payable, principal amount							183,600
Accrued interest							$ 4,590

Note Payable (Details)

Note Payable (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Total notes payable	$ 2,890,000	$ 5,971,261
Unamortized debt discount	0	(47,671)
Notes payable	2,890,000	5,923,590
Less current portion	(2,741,737)
Notes payable, long-term portion	148,263	5,923,590
Promissory note to investor
Total notes payable		2,325,000
Promissory note to investor two
Total notes payable		1,046,261
SBA loan
Total notes payable	150,000
Promissory note to investor three
Total notes payable	140,000
RWJ Advanced Marketing, LLC
Total notes payable	$ 2,600,000	$ 2,600,000

Note Payable (Details 1)

Note Payable (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Notes Payable at beginning	$ 5,923,590
Debt discount at beginning	(47,671)
Amortization of debt discounts	4,197,550	$ 6,821,453
Debt discount at end	0	(47,671)
Notes Payable, at end	2,741,737	5,923,590
Notes Payable [Member]
Notes Payable at beginning	5,923,590	2,699,256
Issued for cash	458,639	3,071,261
Original issue discount		300,000
Repayment of note payable		(99,256)
Accrued interest and penalties added to notes payable	440,983
Notes payable converted to convertible notes	(3,980,883)
Debt discount related to new convertible notes	47,671	(300,000)
Amortization of debt discounts		252,329
Notes Payable, at end	2,890,000	5,923,590
Notes Payable [Member] | Principal [Member]
Notes Payable at beginning	5,971,261	2,699,256
Issued for cash	458,639	3,071,261
Original issue discount		300,000
Repayment of note payable		(99,256)
Accrued interest and penalties added to notes payable	440,983
Notes payable converted to convertible notes	(3,980,883)
Debt discount related to new convertible notes
Amortization of debt discounts
Notes Payable, at end	2,890,000	5,971,261
Notes Payable [Member] | Debt Discount [Member]
Debt discount at beginning	(47,671)
Issued for cash
Original issue discount
Repayment of note payable
Accrued interest and penalties added to notes payable
Notes payable converted to convertible notes
Debt discount related to new convertible notes	47,671	(300,000)
Amortization of debt discounts		252,329
Debt discount at end		$ (47,671)

Note Payable (Details Narrative

Note Payable (Details Narrative) - USD ($)	1 Months Ended					12 Months Ended
	Nov. 15, 2020	Jun. 22, 2020	Feb. 27, 2020	Feb. 27, 2019	Dec. 31, 2017	Dec. 31, 2020	Dec. 31, 2019
Interest expense						$ 2,949,849	$ 6,215,457
Unamortized debt discount						0	47,671
Iliad [Member]
Accrued interest						$ 14,905
Conversion of stock, shares						53,175,795
Stanley [Member]
Interest rate				10.00%
Interst payable date				Feb. 9, 2020
Note payable, principal amount				$ 1,214,900		$ 1,009,469
Conversion of stock, shares						67,282,583
AlphaEda [Member]
Interest rate	10.00%
Interst payable date	Jun. 30, 2021
Note payable, principal amount	$ 140,000					$ 140,000
Accrued interest						1,803
Securities Purchase Agreement | Iliad [Member]
Interst payable date			Aug. 27, 2020
Note payable, principal amount			$ 2,765,983			2,446,746
Accrued interest						$ 14,905
Conversion of stock, shares						53,175,795
Conversion of stock, amount						$ 539,000
Promissory Note [Member]
Interest rate				10.00%
Note payable, principal amount				$ 2,325,000
Original issue discount				300,000
Consideration				2,025,000
Paid for legal fees				$ 25,000
Interest expense						47,671	$ 252,329
Unamortized debt discount						0
RWJ Advanced Marketing, LLC
Interest rate					3.50%
Interst payable date					Dec. 31, 2019
Note payable, principal amount						2,600,000
Accrued interest						307,631
EIDL [Member]
Principal periodic payments		$ 731
Note payable, principal amount						150,000
Term		30 years
Interest rate		3.75%
Accrued interest						$ 3,067

Accrued Settlement (Details Nar

Accrued Settlement (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Dec. 23, 2019	May 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Gain on settlement of debt				$ 1,375,556
Securities Purchase Agreement | Investor
Arbitrator awarded		$ 4,034,444
Interest rate		7.25%
Interest		$ 55,613
Legal matter	$ 8,340,000
Gain on settlement of debt		$ 1,375,556

Derivative Liability (Details)

Derivative Liability (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Stock price	$ 0.017	$ 3.080
Risk free rate	0.10%	1.75%
Volatility	275.00%	650.00%
Conversion/ Exercise price		$ 0.800
Dividend rate	0.00%	0.00%
Minimum [Member]
Conversion/ Exercise price	$ 0.008
Maximum [Member]
Conversion/ Exercise price	$ 0.0085

Derivative Liability (Details 1

Derivative Liability (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Derivative liability balance, Beginning		$ 3,833,506
Issuance of derivative liability	5,767,230	5,721,939
Fair value of beneficial conversion feature of debt repaid/converted	(2,038,392)	(2,264,578)
Change in derivative liability during the period	1,533,610	(7,290,867)
Derivative liability balance, end	$ 5,262,448

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Stockholders' Equity Note [Abstract]
Warrants Outstanding, Beginning	19,654,167	419,167
Warrants Granted		25,355,000
Warrants Forfeited	(10,667)
Warrants Exercised		(6,120,000)
Warrants Outstanding, End	19,643,500	19,654,167
Warrants Exercisable, End	19,643,500
Weighted Average Exercise Price Warrants Outstanding, Beginning	$ 1.57	$ 61
Weighted Average Exercise Price Warrants Granted		0.97
Weighted Average Exercise Price Warrants Forfeited	256.25
Weighted Average Exercise Price Warrants Exercised		0.50
Weighted Average Exercise Price Warrants Outstanding, End	1.50	$ 1.57
Weighted Average Exercise Price Warrants Exercisable at End	$ 1.50
Weighted Average Remaining Contractual Life, Outstanding, Beginning	2 years 9 months 3 days	3 years 5 months 23 days
Weighted Average Remaining Contractual Life, Outstanding, End	1 year 9 months 3 days	2 years 9 months 3 days
Weighted Average Remaining Contractual Life Exercisable at End	1 year 9 months 3 days
Aggregate Intrinsic Value Outstanding, Beginning	$ 1,111,600
Aggregate Intrinsic Value Outstanding, End	0	$ 1,111,600
Aggregate Intrinsic Value Outstanding, Exercisable at End	$ 0

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1) - $ / shares	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Number of warrants Outstanding	19,643,500	19,654,167	419,167
Number of warrants Exercisable	19,643,500
$0.50
Number of warrants Outstanding	15,880,000
Exercise price of warrants Outstanding	$ 0.50
Number of warrants Exercisable	15,880,000
Exercise price of warrants Exercisable	$ 0.50
$1.85
Number of warrants Outstanding	3,000,000
Exercise price of warrants Outstanding	$ 1.85
Number of warrants Exercisable	3,000,000
Exercise price of warrants Exercisable	$ 1.85
$2.70
Number of warrants Outstanding	500,000
Exercise price of warrants Outstanding	$ 2.70
Number of warrants Exercisable	500,000
Exercise price of warrants Exercisable	$ 2.70
$31.90
Number of warrants Outstanding	20,000
Exercise price of warrants Outstanding	$ 31.90
Number of warrants Exercisable	20,000
Exercise price of warrants Exercisable	$ 31.90
$50.00
Number of warrants Outstanding	100,000
Exercise price of warrants Outstanding	$ 50
Number of warrants Exercisable	100,000
Exercise price of warrants Exercisable	$ 50
$75.00
Number of warrants Outstanding	75,000
Exercise price of warrants Outstanding	$ 75
Number of warrants Exercisable	75,000
Exercise price of warrants Exercisable	$ 75
$100.00
Number of warrants Outstanding	50,000
Exercise price of warrants Outstanding	$ 100
Number of warrants Exercisable	50,000
Exercise price of warrants Exercisable	$ 100
$235.00
Number of warrants Outstanding	10,000
Exercise price of warrants Outstanding	$ 235
Number of warrants Exercisable	10,000
Exercise price of warrants Exercisable	$ 235
$250.00
Number of warrants Outstanding	7,500
Exercise price of warrants Outstanding	$ 250
Number of warrants Exercisable	7,500
Exercise price of warrants Exercisable	$ 250
$280.00
Number of warrants Outstanding	1,000
Exercise price of warrants Outstanding	$ 280
Number of warrants Exercisable	1,000
Exercise price of warrants Exercisable	$ 280

Stockholders' Equity (Details 2

Stockholders' Equity (Details 2)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Risk free interest rate	0.10%	1.75%
Expected volatility	275.00%	650.00%
Warrant [Member]
Risk free interest rate		1.55%
Expected volatility		185.00%
Expected dividend yield		0.00%
Warrant [Member] | Minimum [Member]
Expected life of the options		3 years 1 month 6 days
Warrant [Member] | Maximum [Member]
Expected life of the options		3 years 7 months 6 days

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 17, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2014	Nov. 02, 2011
Reverse stock split		1 for 100
Stock issued for Services, Value			$ 235,900
Conversion price (in dollars per share)			$ 0.800
Debt conversion, converted instrument, Value		$ 1,306,489
Debt conversion, converted instrument, shares		140,138,107
Debt conversion, converted instrument, Accrued interest		$ 4,590
Shares issued for joint venture, shares		100,000,000
Shares issued for joint venture, value		$ 5,500,000
Shares cancelled		200,000
Common stock in connection with cashless exercise, shares			4,566,214
Number of warrants issued			6,120,000
Warrants issued			25,245,000
Fair value of warrants			$ 120,476,603
Minimum [Member]
Conversion price (in dollars per share)		$ 0.008
Warrant exercise price			$ 0.50
Minimum [Member]
Conversion price (in dollars per share)		$ 0.0085
Warrant exercise price			$ 2.70
Investor
Number of shares converted			74,762
Stock issued for disputed penalties, shares			59,820
Stock issued for disputed penalties, value			$ 975,065
Investor | Principal [Member]
Debt conversion, converted instrument, Value			1,357,200
Investor | Accrued Interest [Member]
Debt conversion, converted instrument, Value			$ 62,934
Series H Convertible Preferred Stock [Member]
Preferred stock, issued		20,000	20,000
Preferred stock, Outstanding		20,000	20,000
Series G Convertible Preferred Stock [Member]
Preferred stock, issued		0	0
Preferred stock, Outstanding		0	0
Series D Convertible Preferred Stock [Member]
Preferred stock, issued		0	0
Preferred stock, Outstanding		0	0
Series C Convertible Preferred Stock [Member]
Preferred stock, issued		700	700
Preferred stock, Outstanding		700	700
Series B Convertible Preferred Stock [Member]
Preferred stock, issued		45,000	45,000
Preferred stock, Outstanding		45,000	45,000
Conversion price (in dollars per share)					$ 30
Gv Global Communications Inc [Member] | Series C Convertible Preferred Stock [Member]
Preferred stock, Outstanding		700	700
Debt conversion, converted instrument, Value				$ 7,770
Stock issued during period, shares, stock splits				120
Stock issued during period, additional shares, stock splits				42
BitSpeed
Shares issued for joint venture, value			$ 10,000,000
Stock issued for disputed penalties, shares			17,900,000
Altcorp [Member] | Series H Convertible Preferred Stock [Member]
Number of shares converted	20,000
Stock Issued for Acquisitions, Shares	625,000
Conversion price (in dollars per share)	$ 10
Debt conversion, converted instrument, Value	$ 10,000,000
Interest rate	6.00%
Maturity date	Dec. 31, 2021
Dividend per share	$ 500
Employees and Board Members [Member]
Stock issued for Services, Shares			9,500
Stock issued for Services, Value			$ 235,900

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Deferred income tax asset
Net operation loss carryforwards	$ 8,232,796	$ 7,424,074
Total deferred income tax asset	8,232,796	7,424,074
Less: valuation allowance	(8,232,796)	(7,424,074)
Total deferred income tax asset

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal statutory rates	$ (3,757,564)	$ (39,166,075)
State income taxes	(1,431,453)	(14,920,410)
Permanent differences	4,380,295	52,480,331
Valuation allowance against net deferred tax assets	808,722	1,606,154
Effective rate
Federal statutory rates (in percent)	21.00%	21.00%
State income taxes (in percent)	8.00%	8.00%
Permanent differences (in percent)	(24.50%)	(28.10%)
Valuation allowance against net deferred tax assets (in percent)	(4.50%)	(0.90%)
Effective rate (in percent)	0.00%	0.00%

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Valuation allowance	$ 808,722	$ 1,606,154
Net operating loss carryforward	$ (28,390,000)
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2024

Related Parties (Details Narrat

Related Parties (Details Narrative) - USD ($)	Mar. 06, 2020	Jan. 02, 2019	Oct. 10, 2018	Apr. 06, 2018	Sep. 02, 2017	Dec. 31, 2020	Dec. 30, 2019
Related Party Transaction [Line Items]
Payment for legal services						$ 10,000	$ 90,000
RWJ Advanced Marketing, LLC
Related Party Transaction [Line Items]
Base Salary					$ 250,000
Director [Member]
Related Party Transaction [Line Items]
Base Salary				$ 250,000
Additional salary payable				$ 70,000
Tokenize Agreement
Related Party Transaction [Line Items]
Common stock contributed	100,000,000
Principlal amount	$ 10,000,000
Consideration for services payable	$ 33,333
Debt instrument term	2 years
BitSpeed Agreement
Related Party Transaction [Line Items]
Common stock contributed			100,000,000
Value of common stock contributed			$ 17,900,000
Employment Agreement | Davis [Member]
Related Party Transaction [Line Items]
Base salary		$ 400,000
Stock option issued		50,000
Option vested description		The options will be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the six (6) month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event.

Contingencies (Details Narrativ

Contingencies (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Jul. 28, 2020	May 31, 2019	Dec. 31, 2019	Dec. 31, 2020	Dec. 03, 2018
Unearned revenue			$ 249,094	$ 249,094
Sought value	$ 48,844
Legal cost	$ 716
GBT Technologies [Member]
Revenues			300,000
Payment for expenses			5,000,000
Unearned revenue			$ 200,000	$ 200,000
Securities Purchase Agreement | Investor
Arbitrator awarded		$ 4,034,444
Interest rate		7.25%
Interest		$ 55,613
Securities Purchase Agreement | Senior Secured Redeemable Convertible Debenture [Member]
Note payable, principal amount					$ 8,340,000
Note payable, interest rate					2.00%
Warrants aquire					225,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Mar. 15, 2021	Jan. 02, 2021	Feb. 10, 2021	Jan. 19, 2021	Feb. 28, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Convertible promissory note							$ 13,788,710	$ 11,000,000
Debt conversion, converted instrument, Value							$ 1,306,489
Debt conversion, converted instrument, shares							140,138,107
Subsequent Event [Member]
Debt conversion, converted instrument, shares						224,185,847
Consulting agreements, description				The terms of the agreements are for one consultant a 12,000,000 Company one-time new shares issuance and $1,000 cash monthly payment, and to the second consultant 250,000 Company one-time new shares issuance, along with additional 30,000 new issuance per quarter, and $500 cash monthly payment. The company issued to the consultants the 12,250,000 restricted stock on February 11, 2021.
Debt maturity extension fee					$ 1,000
Subsequent Event [Member] | Securities Purchase Agreement | Redstart [Member]
Convertible promissory note	$ 106,200		$ 184,200
Note payable, interest rate			6.00%
Purchase price	$ 88,500		$ 153,500
Maturity date	Jun. 15, 2022		Feb. 5, 2022
Subsequent Event [Member] | Settlement Agreement
Note payable, principal amount		$ 3,300,000
Monthly payment		$ 100,000